rfhg_26555.1

Basic information about the TSS

---

TSS ID: rfhg_26555.1 Species: human Chr: chr2		Start: 54456397 End: 54456402 Strand: +
Source datasets	DRA013844
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AB209748:37 GeneID: 6711 HGNC/MGI_ID: HGNC:11275 UniProt_ID: Nearer transcript ids and distances: ENST00000356805.9:-70 NM_003128.3:-70 AB371586:-70 ENST00000615901.4:-80 EU794662:-80 LF209017:-102 MA444594:-102 view more...

Gene_name: spectrin beta, non-erythrocytic 1 Gene_symbol: SPTBN1 Gene_synonyms: Gene_source: HGNC:11275

TATA-Box annotation

---

Distance to TSS:	72
Nearest PromoterID:	NM_003128
Entrez ID:	6711
Nearest Unigene:	Hs.503178
Nearest Refseq:	NM_003128
Nearest Ensembl:	ENSG00000115306
Gene Name:	spectrin beta, non-erythrocytic 1
Gene Alias:	ELF|HEL102|SPTB2|betaSpII
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.666667
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SPTBN1 p3@SPTBN1 p4@SPTBN1 p5@SPTBN1 p6@SPTBN1 p7@SPTBN1 p9@SPTBN1
Sample		p1@SPTBN1	p3@SPTBN1	p4@SPTBN1	p5@SPTBN1	p6@SPTBN1	p7@SPTBN1	p9@SPTBN1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	21.04	16.36	1.95	1.56	1.56	1.95	0.78
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	22.86	14.97	1.82	0.61	3.84	1.01	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	20.45	14.47	0.58	0.96	2.70	1.16	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	14.97	13.31	0.62	0.42	2.70	1.25	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	16.87	11.92	1.57	0.45	2.92	0.67	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	18.61	12.60	1.16	0.78	1.74	1.36	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	25.71	17.87	1.96	0.22	4.14	0.65	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	21.07	13.56	0.48	0.24	2.18	1.94	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	16.46	16.46	1.92	0.85	3.21	1.28	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	25.50	16.81	1.16	1.74	6.96	1.16	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	21.42	19.00	0.00	0.81	10.51	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	28.87	26.83	0.00	1.63	5.69	1.63	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	62.38	38.69	5.32	0.97	3.55	2.90	3.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	47.06	39.54	5.11	0.75	4.51	3.46	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	59.72	35.13	4.17	1.54	2.42	2.20	2.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	46.78	32.95	5.28	2.01	2.01	2.77	2.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	41.06	28.39	3.71	0.66	2.40	1.97	3.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	49.35	32.48	6.75	0.84	3.80	3.80	3.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	44.25	27.19	1.07	0.53	2.67	4.27	4.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	49.65	36.11	3.61	1.20	2.71	3.01	2.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	46.38	43.57	4.14	1.20	4.54	3.21	1.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	42.64	32.63	4.14	1.38	2.93	3.11	3.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	47.70	39.81	4.01	0.78	3.49	4.52	2.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	44.89	41.50	4.61	1.70	3.15	4.37	3.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	49.02	38.44	4.64	0.77	4.13	4.64	3.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	46.21	34.82	5.70	0.00	4.43	3.48	2.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	53.30	31.87	4.40	1.65	9.89	2.75	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	58.00	58.23	5.66	1.65	6.37	4.24	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	42.32	47.16	3.07	0.65	5.49	3.07	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	48.14	51.58	3.80	0.54	5.25	2.71	3.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	42.50	52.55	3.77	1.47	5.86	2.93	3.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	41.81	46.31	2.93	1.56	5.08	3.13	1.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	45.37	44.32	3.80	1.06	6.33	3.17	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	38.60	60.37	4.29	1.15	9.24	6.43	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	45.63	53.11	3.55	2.43	5.61	3.37	2.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	49.63	52.70	4.60	1.72	5.75	2.11	2.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	44.15	54.98	5.11	1.64	3.68	3.88	2.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	43.32	47.55	3.63	1.01	5.44	3.63	2.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	51.05	46.73	2.43	1.08	6.75	2.43	3.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	51.61	48.49	4.08	1.68	5.28	3.12	3.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	43.05	54.58	4.47	1.18	7.76	4.47	3.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	41.87	51.68	3.51	0.29	5.12	3.81	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	56.10	53.36	3.80	1.90	5.27	3.37	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	57.69	58.22	4.55	0.70	7.34	4.55	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	61.44	59.03	4.22	2.01	5.62	4.02	3.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	52.81	55.14	4.19	0.93	5.12	2.56	2.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	58.06	57.82	4.56	1.92	5.28	4.08	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	52.75	46.20	2.98	2.38	5.96	3.87	1.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	56.73	51.23	3.59	2.39	4.79	2.87	2.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	59.04	54.19	4.04	1.21	4.65	5.26	1.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	56.77	60.67	3.69	1.02	7.38	3.07	2.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	66.05	77.39	6.89	1.78	8.89	5.78	1.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	83.95	167.91	27.98	0.00	0.00	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	50.74	81.97	5.32	2.13	6.74	5.32	3.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	48.05	79.20	3.31	1.66	8.62	4.97	3.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	52.01	99.83	11.75	1.68	9.23	6.71	5.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	44.09	78.07	4.59	1.84	9.64	5.97	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	42.13	76.17	4.86	2.59	6.81	6.48	3.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	44.00	76.44	4.82	1.93	7.39	2.25	1.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	38.35	76.38	4.71	2.51	10.06	5.97	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	43.71	91.66	4.94	1.41	7.76	5.64	4.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	55.52	75.71	4.49	1.12	3.93	5.61	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	118.63	54.14	4.78	3.18	5.57	3.18	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	67.27	60.48	5.44	1.36	7.14	2.38	1.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	72.46	80.91	6.50	2.60	5.52	4.22	4.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	62.48	70.64	4.61	2.48	3.90	6.03	3.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	145.48	0.00	0.00	16.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	181.64	142.15	7.90	15.79	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	64.35	67.76	6.83	1.46	5.36	5.85	3.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	54.55	67.44	7.93	1.98	5.45	6.45	2.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	58.17	60.98	3.28	2.81	8.91	4.22	2.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	72.53	54.65	6.29	2.65	7.29	3.31	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	68.36	75.48	7.42	2.17	4.33	4.64	4.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	66.04	77.66	8.56	2.45	5.81	3.06	2.45
Adipocyte - breast, donor1	11376-118A8	150.31	2.53	11.56	1.90	0.63	0.16	1.43
Adipocyte - breast, donor2	11327-117E4	140.21	4.01	5.45	1.44	0.32	0.64	0.80
Adipocyte - omental, donor1	11473-119C6	234.99	7.25	12.09	1.40	1.40	0.64	2.29
Adipocyte - omental, donor2	11474-119C7	162.95	3.74	14.20	0.00	0.00	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	131.96	3.01	5.36	1.00	1.00	1.34	2.34
Adipocyte - perirenal, donor1	11476-119C9	123.13	11.48	9.57	0.64	4.47	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	25.29	2.20	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	67.74	0.90	1.81	0.45	0.00	0.45	1.35
Adipocyte - subcutaneous, donor3	11408-118E4	126.68	0.17	1.39	1.39	0.00	0.00	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	119.49	1.17	7.82	1.56	0.00	0.20	1.56
Adipocyte differentiation, day04, donor2	13022-139D7	57.91	1.29	2.06	0.51	0.00	0.26	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	73.32	0.56	4.18	1.95	0.00	0.00	2.51
Adipocyte differentiation, day04, donor4	13028-139E4	258.64	1.76	14.11	0.59	0.00	0.00	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	586.92	0.97	20.43	4.42	0.08	0.40	3.38
Adipocyte differentiation, day08, donor2	13023-139D8	173.64	0.65	3.55	2.26	0.00	0.00	1.29
Adipocyte differentiation, day08, donor3	13026-139E2	222.34	1.60	7.46	2.13	0.00	0.00	3.20
Adipocyte differentiation, day08, donor4	13029-139E5	270.98	0.56	6.68	3.90	0.00	0.00	1.67
Adipocyte differentiation, day12, donor1	13021-139D6	289.46	0.42	13.72	3.74	0.00	0.42	4.16
Adipocyte differentiation, day12, donor2	13024-139D9	179.08	0.00	9.04	2.76	0.00	0.00	1.26
Adipocyte differentiation, day12, donor3	13027-139E3	205.84	0.98	6.22	2.95	0.00	0.00	1.64
Adipocyte differentiation, day12, donor4	13030-139E6	307.52	0.91	7.61	6.70	0.00	0.30	1.83
Alveolar Epithelial Cells, donor1	11510-119G7	33.15	36.46	2.21	0.88	3.98	0.88	0.88
Alveolar Epithelial Cells, donor2	11590-120G6	17.21	24.02	1.08	0.72	1.43	0.72	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	13.18	13.18	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	144.10	120.54	7.02	0.18	7.38	5.76	1.08
Amniotic Epithelial Cells, donor2	11613-122A2	93.72	26.78	3.35	0.00	1.67	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	109.09	48.49	5.55	0.41	5.14	4.73	0.82
Anulus Pulposus Cell, donor1	11248-116E6	41.88	5.61	9.96	0.92	0.34	1.49	1.14
Anulus Pulposus Cell, donor2	11463-119B5	55.10	8.33	9.06	1.71	0.73	1.22	1.96
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	56.61	8.09	4.94	0.00	0.00	0.00	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	65.56	4.34	3.47	1.30	0.00	0.87	2.60
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	29.96	4.28	2.14	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	47.23	5.68	2.69	0.90	0.00	0.60	2.09
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	54.38	10.12	1.26	2.53	0.00	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	38.28	1.98	1.98	1.32	0.00	0.66	3.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	47.76	6.17	3.57	0.97	0.00	0.32	1.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	55.34	7.28	3.40	0.49	0.00	0.97	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	49.29	2.38	3.56	0.00	0.00	0.00	1.78
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	58.76	3.01	1.51	0.75	0.00	0.38	2.26
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	55.15	5.81	2.90	0.00	0.00	0.73	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	27.58	5.02	3.76	1.25	0.00	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	54.53	6.75	4.78	1.32	0.00	0.82	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	76.43	8.19	4.09	1.36	0.00	2.73	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	35.29	5.13	2.56	1.06	0.00	0.15	0.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	71.26	6.97	5.36	0.54	0.00	0.54	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	55.36	7.18	2.83	0.94	0.00	0.57	1.89
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	48.65	3.74	4.28	1.34	0.27	0.80	1.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	67.31	0.00	0.98	1.95	0.00	0.98	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	53.57	5.47	3.81	1.33	0.00	1.00	1.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	42.03	2.40	1.20	1.20	0.00	0.00	4.80
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	46.02	14.16	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	67.58	6.69	4.63	0.86	0.00	0.69	2.06
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	46.14	0.00	4.19	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	64.08	2.91	1.46	0.49	0.49	1.46	2.91
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	59.19	7.21	6.07	0.76	0.38	0.00	2.28
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	54.51	7.27	2.42	0.00	0.00	1.21	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	42.75	2.85	4.56	1.14	0.00	2.28	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	49.60	6.41	4.92	0.64	0.00	0.21	2.35
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	44.13	3.10	4.39	2.32	0.00	0.52	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	44.57	5.63	6.57	0.94	0.00	0.47	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	53.38	6.43	2.25	0.64	0.00	0.96	2.57
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	36.39	4.28	1.43	0.71	0.00	0.71	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	54.99	5.85	1.75	1.17	0.00	0.58	2.34
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	54.80	5.42	2.41	0.30	0.00	0.60	2.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	38.02	4.75	2.38	1.19	0.00	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	60.52	6.61	3.56	1.02	0.00	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	47.63	6.37	3.57	0.51	0.00	0.25	2.04
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	35.58	6.35	3.18	1.91	0.00	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	66.02	9.49	3.02	0.86	0.00	0.43	2.16
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	49.32	6.35	3.18	0.42	0.00	0.21	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	37.12	3.77	2.61	0.29	0.00	0.29	1.16
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	80.30	2.83	4.72	0.94	0.00	0.94	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	47.13	5.93	3.39	0.85	0.00	0.68	1.02
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	46.33	4.63	4.63	2.32	0.00	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	59.15	2.11	8.45	0.00	0.00	2.11	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	54.89	5.79	3.43	0.21	0.00	0.21	2.36
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	46.33	3.61	1.80	0.60	0.00	0.60	1.80
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	47.38	4.37	3.64	0.73	0.00	0.00	3.64
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	61.15	8.97	5.06	1.84	0.00	0.46	2.07
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	43.36	5.10	2.55	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	42.71	3.31	3.05	0.76	0.00	0.51	1.27
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	57.18	6.81	4.54	0.41	0.00	0.21	1.45
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	48.96	4.59	2.45	0.31	0.00	1.84	2.75
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	60.71	5.74	4.30	0.00	0.00	0.96	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	58.32	5.99	3.55	0.67	0.00	0.22	1.55
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	42.72	0.00	4.58	1.53	0.00	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	50.40	2.77	1.66	1.11	0.00	0.55	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	52.43	4.77	3.18	1.06	0.00	0.26	1.59
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	38.16	5.09	2.91	0.00	0.00	0.36	1.09
Astrocyte - cerebellum, donor1	11500-119F6	39.30	17.44	3.19	0.61	0.86	3.19	1.84
Astrocyte - cerebellum, donor2	11580-120F5	43.30	19.00	2.57	0.86	0.86	2.57	0.86
Astrocyte - cerebellum, donor3	11661-122F5	31.25	2.10	1.89	0.63	0.00	0.00	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	50.20	11.85	10.81	1.39	0.70	3.83	2.44
Astrocyte - cerebral cortex, donor2	11316-117D2	52.41	30.74	11.16	1.78	1.94	4.04	3.07
Astrocyte - cerebral cortex, donor3	11392-118C6	51.61	21.78	8.20	2.54	1.34	2.68	2.24
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	1.26	119.50	0.57	0.11	17.89	7.80	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	1.50	106.49	0.38	0.50	21.67	4.76	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	1.59	105.26	0.68	0.11	19.35	7.28	0.11
Basophils, donor1	12241-129G9	0.00	31.38	0.00	0.00	2.09	3.14	0.00
Basophils, donor2	12242-129H1	0.00	41.85	0.36	0.00	2.89	4.69	0.00
Basophils, donor3	12243-129H2	8.53	15.58	0.00	0.00	1.18	2.06	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	0.43	27.17	0.00	0.00	3.23	2.16	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	2.29	16.00	0.00	0.00	0.46	0.91	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	28.69	0.00	0.00	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	0.63	38.29	0.00	0.00	2.51	1.88	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	2.70	60.31	0.42	0.00	2.70	4.57	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	4.15	62.64	0.00	0.00	4.84	4.84	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	3.60	45.71	0.36	0.00	3.24	5.22	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	0.00	0.00	0.00	0.72	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	3.03	29.35	0.00	0.23	7.69	3.49	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	9.27	37.41	0.64	1.60	7.04	4.48	1.92
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	217.18	0.00	0.00	20.68	10.34	0.00
CD14+ Monocytes, donor1	11224-116B9	2.25	14.09	0.56	0.00	3.38	1.13	0.00
CD14+ Monocytes, donor2	11305-117B9	0.00	19.12	0.00	0.00	2.04	2.97	0.00
CD14+ Monocytes, donor3	11381-118B4	0.22	25.91	0.00	0.00	3.73	1.76	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	0.00	2.83	0.00	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	0.00	10.99	0.00	0.00	0.38	2.65	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	0.00	2.96	0.00	0.00	0.00	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	0.00	2.02	0.00	0.00	0.00	0.14	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	0.00	8.75	0.00	0.00	0.60	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	0.00	5.69	0.00	0.00	0.47	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	0.00	2.34	0.00	0.00	0.00	0.33	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	0.00	6.35	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	0.00	2.48	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	0.00	16.64	0.00	0.00	0.98	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	0.18	17.09	0.00	0.00	0.53	0.36	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	0.00	24.37	0.00	0.00	0.87	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	0.00	2.34	0.00	0.00	0.00	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	0.00	2.64	0.00	0.00	0.00	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	0.00	1.11	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	0.00	2.08	0.00	0.00	0.15	0.45	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	0.00	9.58	0.00	0.00	0.60	0.40	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	0.00	2.71	0.00	0.00	0.42	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	0.00	1.37	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	0.00	4.75	0.00	0.00	0.68	0.45	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	0.00	1.31	0.00	0.00	0.00	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	0.00	15.87	0.00	0.00	0.81	0.54	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	0.00	26.52	0.00	0.17	1.40	0.17	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	0.00	29.88	0.00	0.00	1.68	0.84	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	0.00	0.55	0.00	0.00	0.00	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	0.00	2.82	0.00	0.00	0.35	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	0.00	0.44	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	0.00	13.43	0.00	0.00	0.35	0.17	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	0.37	20.44	0.00	0.00	1.49	0.74	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	0.00	23.06	0.00	0.00	1.08	0.65	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	22.93	2.46	0.41	0.00	0.00	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	0.00	3.25	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	0.00	0.23	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	0.00	0.87	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	0.00	1.39	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	0.00	0.43	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	0.00	2.18	0.00	0.00	0.16	0.62	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	0.00	1.22	0.00	0.00	0.00	0.35	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	0.00	3.57	0.00	0.00	0.00	0.89	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	0.00	0.51	0.00	0.00	0.00	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	0.00	0.66	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	0.00	63.00	0.00	0.00	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	1.36	57.63	0.00	0.00	5.42	3.39	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	0.00	62.14	0.00	0.00	5.18	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	0.00	74.63	0.00	0.00	6.40	3.20	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	0.00	98.64	0.00	0.00	5.90	3.75	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	0.70	69.49	0.00	0.00	4.91	3.51	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	0.78	62.75	0.00	0.78	3.92	3.14	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	1.32	69.87	0.00	0.00	2.64	5.27	0.00
CD19+ B Cells, donor1	11544-120B5	0.82	136.44	0.00	0.00	23.84	3.29	0.00
CD19+ B Cells, donor2	11624-122B4	0.00	94.31	0.00	0.00	13.06	3.63	0.00
CD19+ B Cells, donor3	11705-123B4	0.00	109.55	0.50	0.00	11.61	4.04	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	0.00	3.23	0.00	0.00	0.00	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	0.00	2.40	0.00	0.00	0.00	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	3.01	37.15	1.00	0.00	6.02	7.03	3.01
CD34+ Progenitors, donor2	11625-122B5	5.06	61.24	0.00	0.00	5.06	4.49	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	5.26	31.56	1.13	0.00	5.26	4.13	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	2.93	28.19	0.23	0.23	2.25	3.38	0.23
CD4+ T Cells, donor1	11225-116C1	0.71	189.95	0.00	0.00	27.49	22.85	0.00
CD4+ T Cells, donor2	11306-117C1	0.00	181.87	0.00	0.00	25.72	14.70	0.00
CD4+ T Cells, donor3	11382-118B5	0.00	150.97	0.00	0.00	16.47	13.11	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	0.00	77.34	0.00	0.00	5.87	8.93	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	0.00	90.29	0.00	0.00	15.27	6.51	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	0.00	83.65	0.00	0.00	10.06	7.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	0.00	63.53	0.00	0.00	9.48	6.64	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	0.00	66.02	0.00	0.00	11.94	4.92	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	102.18	0.00	0.00	9.89	6.59	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	0.00	35.12	0.00	0.00	2.02	7.51	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	0.00	49.99	0.00	0.00	4.41	3.90	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	0.00	44.82	0.00	0.00	2.42	5.32	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	0.00	37.21	0.00	0.00	2.24	4.03	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	0.00	35.99	0.00	0.00	4.54	6.99	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	0.00	78.76	0.00	0.00	4.40	9.68	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	0.42	59.03	0.00	0.00	10.96	18.13	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	0.00	46.33	0.00	0.00	6.03	4.36	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	0.00	35.42	0.00	0.00	3.34	6.01	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	0.00	111.22	0.00	0.00	18.76	15.23	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	0.00	95.93	0.00	0.00	21.97	11.25	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	0.00	170.36	0.00	0.00	32.28	14.35	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	0.00	69.54	0.00	0.00	7.23	11.13	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	0.00	45.06	0.00	0.00	5.42	4.98	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	0.00	50.65	0.00	0.00	5.04	8.41	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	0.00	67.75	0.00	0.00	4.55	8.60	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	0.43	52.42	0.00	0.00	7.37	4.33	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	0.44	113.75	0.00	0.00	10.90	13.95	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	0.00	86.60	0.49	0.00	9.90	12.37	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	0.00	63.70	0.00	0.00	10.16	5.54	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	0.00	58.62	0.00	0.00	4.19	5.58	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	0.00	81.14	0.00	0.00	11.35	12.74	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	0.00	100.36	0.00	0.00	12.02	13.50	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	1.54	98.56	0.00	0.00	12.32	3.08	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	0.00	87.02	0.36	0.00	7.88	15.76	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	0.00	69.25	0.00	0.00	9.69	8.31	0.00
CD8+ T Cells, donor1	11226-116C2	0.33	109.68	0.00	0.00	20.95	14.08	0.00
CD8+ T Cells, donor2	11307-117C2	0.00	107.75	0.00	0.00	13.52	10.14	0.00
CD8+ T Cells, donor3	11383-118B6	0.25	117.15	0.25	0.00	20.20	9.34	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	4.82	0.00	0.46	0.69	0.00	0.00	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	4.07	0.00	0.72	0.96	0.00	0.00	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	4.92	0.00	2.19	1.09	0.00	0.00	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	3.60	0.00	2.70	1.20	0.00	0.00	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	4.80	0.00	1.20	1.44	0.00	0.00	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	10.23	0.00	0.68	0.45	0.00	0.00	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	5.00	0.00	2.61	0.00	0.00	0.00	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	8.42	0.00	2.63	0.26	0.00	0.00	1.05
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	7.27	0.00	2.58	0.47	0.00	0.00	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	3.32	0.00	1.21	1.21	0.00	0.00	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	5.23	0.00	1.74	0.58	0.00	0.00	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	7.19	0.00	0.27	0.53	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	10.51	0.00	3.06	0.44	0.00	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	15.48	0.00	0.91	0.91	0.00	0.00	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	17.16	0.00	3.73	0.75	0.00	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	10.08	0.00	1.44	0.72	0.00	0.00	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	7.48	0.00	2.30	0.58	0.00	0.00	1.15
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	5.42	0.24	0.94	0.24	0.00	0.00	1.41
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	8.87	0.00	2.54	1.58	0.00	0.00	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	7.07	0.00	1.85	1.23	0.00	0.00	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	6.09	0.00	4.17	0.64	0.00	0.00	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	4.97	0.00	0.76	1.15	0.00	0.00	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	4.73	0.00	1.18	0.79	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	9.83	0.00	0.00	1.51	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	7.23	0.00	2.41	0.00	0.00	0.00	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	9.09	0.00	2.10	1.40	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	15.03	0.00	2.00	3.01	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	268.68	0.00	5.48	1.83	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	93.88	11.86	0.99	0.00	1.48	0.99	2.47
Cardiac Myocyte, donor3	11686-122I3	122.70	19.05	5.58	1.37	0.42	2.00	1.47
Chondrocyte - de diff, donor1	11261-116G1	103.31	6.24	11.09	1.04	0.00	1.73	2.08
Chondrocyte - de diff, donor2	11338-117F6	66.81	3.91	4.98	0.36	0.36	0.36	0.36
Chondrocyte - de diff, donor3	11410-118E6	53.48	2.28	6.26	0.68	0.00	0.91	0.91
Chondrocyte - re diff, donor2	11339-117F7	77.89	6.27	3.58	0.90	0.00	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	57.83	1.62	3.24	0.40	0.00	1.21	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	71.95	38.10	5.74	1.84	1.38	2.87	1.95
Ciliary Epithelial Cells, donor2	11323-117D9	42.54	45.75	4.06	1.92	1.71	3.42	1.92
Ciliary Epithelial Cells, donor3	11399-118D4	40.00	57.35	4.69	1.33	2.92	3.45	1.33
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	393.76	15.86	17.61	9.45	7.24	1.93	4.03
Corneal Epithelial Cells, donor1	11526-119I5	1.10	11.20	0.00	0.00	0.44	1.10	0.00
Corneal Epithelial Cells, donor2	11606-120I4	1.14	18.20	0.00	0.00	3.41	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	2.56	17.89	0.00	0.00	1.79	3.07	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	0.00	0.33	0.00	0.00	0.00	0.50	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	0.32	0.00	0.00	0.00	0.32	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	0.00	0.22	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	0.00	22.89	0.00	0.00	8.88	5.47	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	0.00	22.85	0.00	0.00	5.22	2.61	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	0.48	26.62	0.00	0.00	4.84	2.90	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	91.72	19.18	6.50	1.33	0.67	0.67	1.00
Endothelial Cells - Aortic, donor1	11263-116G3	63.96	12.91	1.17	1.76	0.59	2.93	2.93
Endothelial Cells - Aortic, donor2	11340-117F8	192.30	29.13	8.20	0.85	0.57	1.70	3.96
Endothelial Cells - Aortic, donor3	11412-118E8	160.42	14.15	7.86	2.36	0.39	1.18	3.93
Endothelial Cells - Artery, donor1	11264-116G4	100.06	16.29	6.98	0.87	0.29	1.45	2.91
Endothelial Cells - Artery, donor2	11341-117F9	91.29	31.29	10.82	0.94	1.18	3.29	2.82
Endothelial Cells - Artery, donor3	11413-118E9	69.25	25.95	7.19	0.88	1.23	2.98	2.10
Endothelial Cells - Lymphatic, donor1	11236-116D3	249.14	8.20	15.52	1.11	0.44	0.22	3.32
Endothelial Cells - Lymphatic, donor2	11317-117D3	331.04	8.22	20.69	4.26	0.61	1.52	4.26
Endothelial Cells - Lymphatic, donor3	11393-118C7	387.62	14.10	16.35	2.82	0.56	0.56	6.48
Endothelial Cells - Microvascular, donor1	11265-116G5	236.82	13.37	21.69	1.78	0.30	0.00	5.65
Endothelial Cells - Microvascular, donor2	11342-117G1	143.70	5.21	6.77	1.04	0.52	0.00	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	275.92	6.81	17.30	2.55	0.14	0.14	6.52
Endothelial Cells - Thoracic, donor1	11266-116G6	205.66	23.21	12.80	2.80	1.20	3.20	2.00
Endothelial Cells - Thoracic, donor2	11343-117G2	83.86	23.06	6.29	0.52	0.52	1.05	2.10
Endothelial Cells - Umbilical vein, donor1	11243-116E1	215.07	27.33	12.42	2.11	0.99	3.35	2.61
Endothelial Cells - Umbilical vein, donor2	11324-117E1	181.20	19.34	6.08	2.17	0.43	1.96	1.96
Endothelial Cells - Umbilical vein, donor3	11400-118D5	174.15	30.53	10.50	1.10	1.10	4.03	2.56
Endothelial Cells - Vein, donor1	11267-116G7	67.11	25.03	1.14	2.28	1.14	2.28	0.00
Endothelial Cells - Vein, donor2	11344-117G3	104.08	28.64	8.38	1.40	0.70	6.99	0.00
Endothelial Cells - Vein, donor3	11416-118F3	107.71	26.85	5.34	1.10	0.94	0.63	1.88
Eosinophils, donor1	12244-129H3	0.00	76.23	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	0.00	19.80	0.00	0.00	3.30	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	14.27	0.00	0.00	0.00	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	0.49	20.77	0.00	0.00	2.69	2.20	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	0.00	6.24	0.00	0.00	6.24	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	32.54	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	111.66	13.96	8.62	2.46	0.00	0.82	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	37.12	0.55	3.72	0.66	0.00	0.11	0.88
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	47.67	5.42	4.55	0.54	0.22	0.54	0.76
Fibroblast - Aortic Adventitial, donor1	11245-116E3	84.53	30.93	14.67	1.94	1.09	3.15	1.82
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	314.29	6.14	32.48	7.37	0.27	0.82	3.96
Fibroblast - Aortic Adventitial, donor2	11326-117E3	99.98	1.05	7.49	1.79	0.21	0.00	2.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	340.43	42.95	41.10	2.63	2.37	6.32	2.63
Fibroblast - Aortic Adventitial, donor3	11401-118D6	86.04	37.54	14.62	3.32	1.99	2.33	2.33
Fibroblast - Cardiac, donor1	11268-116G8	131.55	11.79	7.71	3.63	1.36	1.36	3.63
Fibroblast - Cardiac, donor2	11345-117G4	77.31	64.43	6.82	0.00	7.58	3.03	0.00
Fibroblast - Cardiac, donor3	11417-118F4	64.19	29.34	6.31	1.42	3.31	1.73	1.42
Fibroblast - Cardiac, donor4	11452-119A3	257.94	8.18	13.64	3.03	0.00	1.52	2.42
Fibroblast - Cardiac, donor5	11456-119A7	100.89	29.70	9.64	1.90	0.76	3.55	2.41
Fibroblast - Cardiac, donor6	11460-119B2	145.83	26.38	8.19	1.97	1.21	3.49	2.12
Fibroblast - Choroid Plexus, donor1	11492-119E7	234.35	8.98	9.38	2.81	0.40	1.07	2.14
Fibroblast - Choroid Plexus, donor2	11572-120E6	170.41	5.18	7.33	3.45	0.00	0.00	1.73
Fibroblast - Choroid Plexus, donor3	11653-122E6	29.30	73.24	4.39	0.00	2.93	7.32	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	33.90	15.91	2.08	0.23	1.38	0.69	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	61.91	0.00	12.04	0.68	0.00	0.17	3.56
Fibroblast - Dermal, donor1	11269-116G9	62.69	2.11	5.87	2.58	0.23	0.23	1.64
Fibroblast - Dermal, donor2	11346-117G5	64.62	8.49	4.25	1.89	0.00	2.36	2.36
Fibroblast - Dermal, donor3	11418-118F5	52.95	0.97	5.80	1.33	0.12	0.60	0.97
Fibroblast - Dermal, donor4	11450-119A1	51.77	11.98	9.61	1.02	0.34	1.81	3.28
Fibroblast - Dermal, donor5	11454-119A5	71.00	12.39	7.50	1.40	0.70	3.31	2.97
Fibroblast - Dermal, donor6	11458-119A9	68.22	10.72	9.26	1.62	0.97	3.74	2.60
Fibroblast - Gingival, donor1	11237-116D4	92.87	16.87	11.04	1.46	0.83	4.37	1.67
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	99.04	15.20	12.05	1.83	0.26	3.67	1.05
Fibroblast - Gingival, donor2	11318-117D4	45.47	22.14	7.38	0.40	0.66	5.14	3.16
Fibroblast - Gingival, donor3	11394-118C8	101.23	15.08	13.34	1.06	0.39	2.51	2.42
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	61.29	0.00	4.16	0.00	0.00	0.00	3.12
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	67.31	1.06	3.88	1.23	0.00	0.35	1.06
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	66.10	15.43	8.42	2.34	0.31	3.59	1.71
Fibroblast - Gingival, donor6 (control)	11922-125H5	72.48	8.38	11.63	1.62	0.41	2.98	2.03
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	57.52	6.35	5.29	1.06	0.00	1.41	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	79.26	13.89	10.68	2.34	0.73	2.34	1.61
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	60.54	18.54	8.73	1.64	0.27	5.73	1.23
Fibroblast - Gingival, donor8 (control)	11926-125H9	61.54	12.61	5.27	1.32	0.55	2.52	1.32
Fibroblast - Gingival, donor9 (control)	11927-125I1	96.55	0.73	7.19	1.61	0.00	0.00	1.47
Fibroblast - Lung, donor1	11270-116H1	61.17	4.08	2.72	1.36	0.00	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	77.59	10.45	13.43	1.49	0.00	0.00	2.98
Fibroblast - Lung, donor3	11419-118F6	49.38	7.18	3.80	1.90	0.21	1.69	2.53
Fibroblast - Lymphatic, donor1	11506-119G3	99.13	5.83	11.66	0.00	0.83	2.50	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	123.08	2.80	4.20	1.40	0.00	0.00	2.80
Fibroblast - Lymphatic, donor3	11667-122G2	23.23	2.24	1.40	0.00	0.00	0.56	0.56
Fibroblast - Mammary, donor1	11540-120B1	68.20	11.37	2.84	2.44	0.81	2.03	2.03
Fibroblast - Mammary, donor2	11620-122A9	31.95	11.98	3.99	0.00	0.00	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	77.43	11.91	0.00	0.00	0.00	0.00	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	41.70	14.55	9.89	0.78	0.58	3.30	2.13
Fibroblast - Periodontal Ligament, donor2	11319-117D5	63.71	26.39	8.80	1.67	0.61	4.40	4.70
Fibroblast - Periodontal Ligament, donor3	11395-118C9	129.13	33.66	14.38	2.14	0.31	6.73	1.84
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	79.00	6.49	8.40	1.53	0.38	1.53	2.29
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	72.36	6.48	2.97	1.62	0.27	1.89	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	73.53	1.97	4.75	1.39	0.23	0.46	1.51
Fibroblast - Pulmonary Artery, donor1	11250-116E8	41.67	36.81	6.85	0.44	1.55	2.65	1.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	47.55	15.65	2.64	0.61	0.81	2.24	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	41.43	6.01	5.35	0.67	0.00	3.34	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	35.98	4.74	5.14	1.19	0.00	1.19	1.19
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	356.41	75.41	38.70	5.75	1.59	21.23	8.14
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	73.00	1.95	6.75	1.24	0.00	0.00	1.07
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	60.51	3.35	5.12	2.17	0.39	0.20	0.99
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	238.88	31.89	23.17	4.51	0.30	5.11	3.61
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	164.09	5.18	14.57	2.59	0.00	1.30	2.05
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	258.64	16.20	24.30	4.05	0.76	4.30	4.30
Fibroblast - skin normal, donor1	11553-120C5	92.21	3.61	9.52	1.31	0.00	0.66	1.48
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	224.17	29.27	33.28	5.81	0.60	7.82	4.61
Fibroblast - skin normal, donor2	11561-120D4	104.38	3.21	12.36	2.41	0.20	0.40	2.01
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	361.48	27.81	31.43	5.44	0.30	9.37	6.35
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	114.58	1.91	7.70	1.74	0.08	0.50	1.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	128.55	1.71	10.77	2.39	0.17	0.17	2.56
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	220.38	13.14	16.75	4.27	0.00	2.30	5.91
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	91.08	8.52	10.87	1.81	0.11	2.13	2.34
Fibroblast - skin walker warburg, donor1	11554-120C6	62.75	17.04	8.94	1.18	0.51	3.04	1.86
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	20.54	2.04	4.23	0.47	0.00	0.16	0.94
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	44.32	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	43.58	15.69	2.61	0.87	3.49	2.61	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	4.85	42.99	0.00	0.00	1.91	3.47	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	10.67	70.00	0.52	0.00	3.12	4.42	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	4.34	47.01	0.00	0.51	3.07	2.81	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	14.55	26.79	2.30	0.00	1.53	3.83	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	14.68	31.90	0.00	0.00	0.64	5.74	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	28.24	81.01	0.29	2.00	4.28	5.42	3.42
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	14.06	33.92	0.55	1.10	2.21	1.10	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	23.06	25.12	0.91	1.37	1.37	1.37	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	28.33	55.48	1.78	0.20	2.77	3.17	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	11.10	25.38	0.26	0.53	1.06	1.32	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	23.48	20.22	1.96	1.63	1.30	1.63	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	46.88	60.58	3.10	1.33	3.10	3.10	3.10
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	16.25	45.51	1.41	0.71	3.53	4.24	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	33.25	38.30	1.85	0.99	2.59	2.71	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	9.67	38.95	1.07	0.27	2.42	3.22	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	48.44	38.41	2.23	0.99	1.49	1.49	2.11
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	32.53	42.22	1.94	0.42	2.08	2.49	2.91
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	15.25	43.51	2.85	1.22	1.83	2.44	2.44
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	64.35	20.99	4.34	1.37	2.05	2.28	2.74
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	45.09	28.40	2.62	1.25	1.49	1.49	2.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	36.94	44.37	3.28	0.87	3.28	1.97	4.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	99.58	17.73	3.84	1.48	0.59	1.18	2.07
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	70.42	27.66	2.07	0.79	1.43	2.38	2.23
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	33.29	25.47	2.46	0.67	2.23	1.34	2.46
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	142.76	14.32	3.02	1.41	1.21	1.21	2.62
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	110.61	20.53	3.39	1.70	1.53	2.37	1.36
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	96.56	44.07	4.61	1.60	4.08	3.37	1.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	260.04	13.53	10.61	1.25	0.94	1.04	3.95
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	201.69	11.95	9.91	1.37	1.20	0.68	3.76
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	194.75	11.62	7.86	1.88	0.89	0.89	2.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	127.62	30.45	4.41	1.41	2.66	1.83	2.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	122.30	30.63	3.47	2.04	2.04	2.04	1.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	151.02	9.90	5.36	2.27	1.24	0.62	2.27
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	159.68	9.92	9.22	1.61	1.38	0.92	4.04
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	186.94	16.34	7.67	1.83	1.00	1.50	2.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	177.89	5.51	11.02	1.76	0.00	0.88	4.19
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	210.69	8.12	10.70	2.95	0.49	1.11	4.06
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	136.48	16.70	6.16	2.11	1.78	0.65	1.62
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	178.64	8.98	8.66	1.60	0.32	0.00	6.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	232.05	5.40	9.10	3.03	0.57	0.95	3.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	206.89	7.28	12.18	1.11	0.32	0.32	4.59
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	261.21	6.08	12.47	3.95	0.30	0.30	6.99
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	229.78	6.27	9.83	1.99	0.21	0.73	3.35
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	213.85	7.90	11.20	0.88	1.10	0.88	5.27
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	208.73	7.29	7.86	1.96	1.40	0.00	5.89
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	326.18	4.81	10.83	2.78	0.19	0.46	5.18
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	218.74	5.88	9.09	2.14	0.53	0.27	2.94
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	220.94	3.98	9.18	2.45	0.15	0.15	4.74
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	193.92	3.76	8.29	1.42	0.13	0.78	2.33
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	271.89	5.42	8.95	4.34	0.00	0.27	2.98
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	234.86	1.84	13.64	2.77	0.18	0.18	4.42
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	269.10	3.07	11.62	3.29	0.00	0.44	5.48
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	411.57	10.91	13.88	4.96	0.99	0.99	7.93
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	171.62	4.22	10.16	1.85	0.40	1.19	5.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	139.21	3.43	9.68	2.62	0.20	0.00	5.25
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	355.06	7.37	17.54	4.32	0.25	1.27	5.85
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	27.67	68.87	2.19	0.40	2.19	9.16	2.19
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	12.63	49.92	0.92	0.15	3.08	5.85	1.69
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	16.37	69.56	1.43	0.20	2.86	7.36	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	10.33	29.42	0.31	0.00	2.19	3.44	1.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	5.65	35.04	0.28	0.00	1.41	1.41	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	8.30	68.72	0.46	1.38	2.77	6.92	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	14.85	44.55	2.47	2.47	0.00	4.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	12.76	39.84	0.39	0.39	2.71	4.64	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	11.23	38.51	1.60	1.60	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	24.34	33.04	0.00	3.48	6.96	3.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	16.60	35.15	0.33	0.33	1.95	1.63	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	22.65	32.94	0.41	0.00	2.47	4.94	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	33.32	36.65	10.00	0.00	0.00	6.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	20.69	22.93	1.12	1.12	2.24	2.24	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	20.26	22.88	0.33	0.65	1.31	0.98	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	30.20	22.65	0.00	0.00	0.84	1.68	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	31.49	19.08	0.64	0.32	2.23	0.64	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	27.51	21.74	1.02	1.36	0.34	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	27.15	25.06	0.00	0.00	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	34.36	19.47	0.00	1.72	1.15	1.15	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	22.20	15.39	1.18	0.00	0.59	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	52.52	22.02	0.00	0.00	1.69	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	31.07	20.71	0.83	0.83	1.24	1.66	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	41.65	18.18	0.92	0.46	1.61	3.22	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	63.22	15.81	0.00	0.00	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	35.75	15.76	1.15	0.77	2.31	2.31	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	28.36	9.45	0.98	0.33	0.65	0.98	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	22.07	7.36	0.67	0.00	1.34	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	41.22	15.80	1.16	0.00	2.70	0.39	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	45.53	16.09	0.34	0.34	0.68	2.05	1.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	64.60	12.42	2.48	0.00	2.48	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	36.33	12.74	2.83	0.47	2.83	0.00	1.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	45.26	10.86	1.21	2.41	1.81	1.21	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	45.27	14.24	1.53	0.00	1.02	0.51	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	46.66	13.96	1.60	0.80	1.20	0.80	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	44.90	15.29	1.48	0.00	0.99	0.99	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	40.13	28.33	0.00	1.18	1.18	0.00	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	38.51	14.00	1.75	2.33	1.75	0.58	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	46.52	10.53	2.19	0.88	1.32	0.88	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	50.86	9.32	0.85	0.85	0.00	0.00	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	56.11	10.15	2.98	1.79	1.79	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	49.50	9.22	0.97	0.49	0.97	3.40	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	49.08	4.57	3.42	3.42	0.00	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	51.98	1.25	2.08	0.83	0.42	1.25	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	41.60	5.62	5.62	1.12	0.00	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	49.79	2.85	4.12	0.95	0.00	0.32	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	41.77	0.00	4.18	0.42	0.00	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	19.26	16.36	2.55	0.23	2.20	3.83	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	18.06	20.26	2.53	0.51	2.70	6.08	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	16.15	16.61	2.96	0.00	4.10	4.10	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	18.25	16.07	2.51	0.66	3.50	3.17	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	20.85	13.75	1.72	1.07	3.44	5.80	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	14.21	12.27	1.72	0.43	4.09	4.74	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	12.95	12.08	1.49	0.75	1.74	3.61	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	14.07	9.78	1.37	0.86	3.26	3.26	0.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	6.41	11.85	0.32	0.00	1.28	1.60	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	166.21	2.24	7.28	1.12	1.12	1.12	6.72
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	53.67	11.25	0.87	0.87	0.87	0.43	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	52.88	13.22	7.93	0.00	0.00	2.64	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	68.08	10.58	7.41	0.35	1.41	0.71	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	61.75	2.91	4.36	0.00	0.73	0.00	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	37.07	36.37	4.90	0.35	2.97	2.62	0.35
Hepatocyte, donor1	11523-119I2	12.11	84.74	0.00	0.00	18.16	6.05	0.00
Hepatocyte, donor2	11603-120I1	53.87	156.21	0.00	2.15	30.17	7.54	0.00
Hepatocyte, donor3	11684-122I1	78.53	67.49	0.61	0.00	19.63	2.45	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.00	16.97	0.00	0.00	5.87	3.92	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	6.29	155.91	0.17	0.00	13.81	4.37	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	39.79	31.69	4.80	0.82	1.92	2.74	1.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	12.74	0.00	0.00	0.00	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	20.03	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	27.08	0.00	0.00	27.08	27.08	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	0.00	13.84	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	5.01	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	23.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	0.00	10.25	0.00	0.00	2.56	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	4.57	0.00	0.00	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	0.00	11.37	0.00	0.00	1.62	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	0.00	11.67	0.00	0.00	1.67	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	14.52	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	0.00	9.26	0.00	0.00	5.29	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	0.00	15.52	0.00	0.00	1.11	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	15.71	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	0.00	12.60	0.00	0.00	1.89	1.89	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	0.00	13.92	0.00	0.00	0.00	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	0.00	13.57	0.00	0.00	5.17	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	0.00	12.88	0.00	0.00	1.61	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	47.79	0.00	0.00	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	0.00	11.41	0.00	0.00	4.07	1.63	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	0.00	15.95	0.00	0.00	2.10	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	14.37	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	0.00	12.06	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	0.00	13.85	0.00	0.00	1.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	15.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	0.00	7.08	0.00	0.00	0.94	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	0.00	6.35	0.00	0.00	0.00	2.72	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	29.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	0.00	9.69	0.00	0.00	3.23	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	1.27	6.35	0.00	0.00	6.35	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	16.43	0.00	0.00	32.86	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	0.64	10.20	0.00	0.00	0.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	0.00	20.05	0.00	0.00	1.82	5.47	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	0.71	10.71	0.00	0.00	2.86	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	9.95	0.00	0.00	0.00	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	0.00	12.04	0.00	0.00	1.54	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	0.00	12.29	0.00	0.00	7.02	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	12.57	0.00	0.00	0.00	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	0.00	11.13	0.00	0.00	2.09	2.09	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	0.00	28.77	0.00	0.00	4.43	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	0.00	16.21	0.00	0.00	6.48	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	6.10	17.44	0.00	0.00	5.23	1.74	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	0.00	36.00	0.00	0.00	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	6.97	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	1.07	21.34	0.00	0.00	8.53	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	0.00	11.08	0.00	0.00	5.54	4.16	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	19.95	0.00	0.00	0.00	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	0.00	10.12	0.00	0.00	1.84	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	21.18	0.00	0.00	3.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	18.63	0.00	0.00	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	0.00	15.86	0.00	0.00	8.46	2.11	0.00
Keratinocyte - epidermal, donor1	11272-116H3	19.01	37.37	0.73	0.08	2.37	4.65	0.16
Keratinocyte - epidermal, donor2	11349-117G8	0.59	29.87	0.00	0.00	1.76	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	1.33	37.58	0.00	0.09	2.18	5.58	0.00
Keratinocyte - oral, donor1	11251-116E9	5.68	50.52	0.45	0.23	3.86	8.06	0.34
Keratocytes, donor1	11527-119I6	16.85	22.01	1.38	0.34	0.69	1.03	0.34
Keratocytes, donor2	11607-120I5	25.78	5.86	1.17	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	45.05	4.94	1.78	0.40	0.79	0.59	1.38
Krukenberg tumor cell line:HSKTC	10687-109F3	98.91	24.18	4.40	0.00	19.78	0.00	4.40
Lens Epithelial Cells, donor1	11529-119I8	19.42	44.23	2.16	0.00	0.00	1.08	2.16
Lens Epithelial Cells, donor2	11609-120I7	50.05	13.96	5.31	1.50	0.46	0.92	1.85
Lens Epithelial Cells, donor3	11690-122I7	84.97	29.57	6.26	1.61	1.31	4.74	2.52
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	199.68	15.30	9.72	1.07	0.47	0.47	2.85
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	96.56	8.93	1.67	1.12	0.28	0.00	1.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	212.98	10.23	8.34	1.57	0.16	0.47	2.68
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	108.08	6.45	6.45	0.54	1.08	0.54	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	173.66	8.82	4.41	0.32	0.32	0.63	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	152.13	6.68	7.44	1.40	0.54	0.22	1.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	132.15	10.67	6.57	0.82	0.82	0.00	2.46
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	100.37	6.32	3.03	0.25	0.25	0.76	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	181.15	9.99	8.59	1.83	0.28	0.56	2.25
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	110.35	15.82	9.89	0.40	0.79	0.79	2.77
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	122.73	8.53	4.85	0.78	0.39	0.58	1.16
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	104.61	7.41	3.89	0.00	0.19	0.19	0.93
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	145.64	11.50	5.92	0.70	0.35	0.35	3.83
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	120.22	6.68	6.92	1.19	0.48	0.72	1.43
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	147.24	8.24	8.93	0.82	0.14	0.14	1.51
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	123.18	11.39	11.09	0.92	0.62	0.31	1.85
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	82.92	7.17	3.43	0.94	0.00	0.31	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	184.09	9.15	7.87	1.83	0.18	0.18	2.93
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	121.11	11.85	7.24	0.99	0.33	0.66	2.30
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	105.73	8.79	4.10	0.29	0.00	0.29	2.05
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	157.57	6.97	5.23	0.75	0.25	0.25	2.74
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	118.33	11.64	9.70	1.45	0.97	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	113.37	11.04	5.66	1.35	0.54	0.27	2.42
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	179.08	10.75	7.72	1.21	0.15	0.61	2.12
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	100.05	7.78	6.74	1.56	0.00	1.04	3.11
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	123.12	11.31	7.12	0.42	0.84	0.84	1.88
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	176.69	8.27	8.12	1.65	0.00	0.75	2.41
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	120.38	12.38	11.01	0.00	0.00	1.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	99.53	11.48	6.02	0.19	0.56	0.56	1.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	165.41	8.69	6.36	0.74	0.42	0.64	2.44
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	103.22	14.54	12.60	0.97	0.97	0.48	2.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	90.31	10.59	5.62	0.66	0.00	0.00	1.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	154.00	8.30	9.42	1.36	0.12	0.62	2.35
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	166.22	19.25	11.48	1.85	0.74	0.00	2.22
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	86.73	10.38	4.45	0.00	0.74	0.25	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	142.03	8.25	7.97	0.41	0.27	0.14	2.47
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	138.30	11.90	7.40	0.64	1.29	0.64	2.57
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	108.04	16.13	7.00	1.22	1.52	0.30	2.74
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	185.04	12.32	7.98	1.82	0.42	1.12	3.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	114.49	9.24	8.89	1.42	0.00	0.71	2.84
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	71.26	6.79	5.82	0.97	0.48	0.48	1.45
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	121.06	6.69	7.31	0.31	0.62	0.31	1.87
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	101.70	9.67	5.73	1.07	0.36	1.07	2.15
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	126.75	13.07	6.53	1.31	0.98	0.98	1.63
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	100.29	3.77	4.47	0.94	0.71	0.71	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	175.11	22.52	12.25	1.24	0.74	0.74	1.73
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	71.72	11.01	3.59	0.51	0.51	0.51	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	144.40	8.35	7.46	1.19	1.19	0.00	3.28
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	2.27	9.06	2.27	0.00	2.27	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	1.53	12.27	0.00	0.00	3.84	3.84	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	2.97	13.36	0.00	0.00	1.48	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	2.54	14.39	0.85	0.00	1.69	2.54	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	2.81	17.58	0.00	0.00	1.41	5.63	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	1.87	12.14	0.00	0.00	5.60	2.80	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	0.52	9.27	0.00	0.00	1.55	2.06	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	0.00	10.71	0.00	0.00	2.38	2.38	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	2.49	11.99	0.00	0.23	1.81	1.58	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	1.74	9.31	0.29	0.00	2.91	4.65	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	2.70	12.15	0.45	0.00	0.90	2.25	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	3.39	14.77	0.27	0.00	3.52	4.34	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	2.57	12.32	0.00	0.00	4.62	4.11	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	1.41	14.11	0.00	0.00	2.47	1.76	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	2.00	13.33	0.00	0.00	5.33	2.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	2.55	12.73	0.51	0.00	1.53	3.06	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	1.60	16.81	0.27	0.00	3.47	2.93	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	4.16	14.93	0.19	0.00	1.70	3.21	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	0.00	9.20	0.00	0.00	1.84	6.14	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	2.45	21.20	0.00	0.00	1.63	4.89	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	2.08	14.58	0.00	0.21	2.29	4.79	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	3.36	12.61	0.00	0.28	3.08	4.48	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	3.09	11.33	0.00	0.00	3.09	6.18	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	3.48	15.68	0.00	0.29	3.48	4.64	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	3.29	11.66	0.00	0.00	2.99	5.08	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	1.11	12.72	0.00	0.00	4.98	4.98	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	5.66	16.97	0.00	0.00	3.89	1.77	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	2.21	9.96	0.74	0.00	4.06	3.69	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	0.00	10.36	0.00	0.00	0.00	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	4.22	13.82	0.38	0.00	2.30	3.84	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	3.96	10.76	0.00	0.00	3.96	2.26	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	0.82	18.05	0.00	0.00	1.64	4.10	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	3.62	14.01	0.45	0.00	2.26	3.62	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	2.87	12.21	0.00	0.00	3.59	2.15	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	2.99	11.95	0.00	0.00	3.73	2.24	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	1.86	15.61	0.00	0.00	2.97	2.60	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	2.58	11.20	0.00	0.00	2.15	1.72	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	5.99	12.84	0.00	0.00	1.71	4.28	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	4.00	18.32	0.00	0.00	3.00	4.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	3.62	15.08	0.60	0.00	3.62	3.62	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	2.84	14.22	0.00	0.00	4.27	2.84	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	3.44	12.72	1.03	0.00	2.75	4.81	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	1.61	16.64	0.00	0.00	3.22	3.22	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	2.69	11.45	0.67	0.00	4.71	5.39	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	7.41	18.15	0.00	0.00	4.07	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	2.33	18.61	0.00	0.00	0.00	4.65	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	1.06	15.87	0.00	0.00	1.06	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	10.40	10.80	1.20	0.00	3.60	8.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	6.54	8.72	0.00	0.00	2.18	2.91	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	2.30	9.20	0.77	1.53	3.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	2.47	17.26	0.00	0.00	1.97	3.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	3.76	16.00	0.00	0.00	1.88	4.70	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	3.52	14.08	0.00	0.00	1.01	4.53	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	5.41	13.52	0.00	0.00	4.51	3.15	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	3.44	8.61	0.00	0.00	5.16	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	3.12	16.92	0.00	0.00	3.56	4.01	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	1.56	17.99	0.39	0.00	2.74	4.69	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	2.64	13.19	0.66	0.00	4.62	3.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	1.56	19.20	0.00	0.00	5.19	4.67	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	2.63	18.38	0.00	0.00	4.38	4.38	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	2.80	8.95	0.00	0.00	4.47	3.35	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	2.21	13.69	0.44	0.00	2.65	2.21	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	3.09	12.73	0.00	0.00	3.09	4.63	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	3.04	13.67	0.00	0.00	4.56	3.54	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	1.92	12.02	0.00	0.00	4.33	3.36	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	7.16	19.48	0.00	0.00	1.99	4.77	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	3.04	9.11	0.00	0.00	0.61	3.04	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	1.38	14.53	0.00	0.00	3.46	3.46	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	1.90	17.86	0.00	0.00	4.18	4.56	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	2.58	12.39	0.00	0.00	4.65	0.52	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	2.42	14.51	0.00	0.00	2.42	6.05	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	9.51	12.99	0.00	0.00	2.54	2.22	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	1.07	16.53	0.53	0.00	6.40	2.13	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	2.30	6.32	0.00	0.57	0.00	5.75	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	3.60	10.80	0.51	0.51	1.03	2.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	4.24	9.90	0.00	0.00	4.24	3.54	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	5.67	9.65	0.00	0.57	1.70	6.24	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	6.66	15.81	0.00	0.00	3.33	1.66	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	4.70	12.53	0.00	0.00	2.35	3.92	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	3.34	10.86	0.00	0.00	2.92	2.51	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	3.25	12.08	0.00	0.00	3.25	3.25	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	3.35	9.37	0.00	0.00	2.01	4.01	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	3.21	15.50	0.00	0.00	1.07	4.28	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	3.23	16.16	0.00	0.40	3.64	3.64	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	2.75	12.85	0.00	0.00	0.92	3.67	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	1.78	13.34	0.00	0.00	2.67	4.45	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	3.42	16.53	0.00	0.57	2.28	5.13	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	0.77	16.10	0.00	0.00	2.30	3.83	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	4.38	20.25	0.00	0.00	2.19	2.74	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	1.78	16.93	0.45	0.89	3.56	2.23	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	2.60	16.38	0.52	0.26	2.34	5.20	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	5.30	9.95	0.00	0.00	3.98	1.33	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	8.31	18.71	0.00	0.00	8.31	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	0.00	0.46	0.00	0.00	0.00	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	0.00	2.94	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	0.00	2.49	0.00	0.00	0.00	0.66	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	4.25	23.90	0.53	0.00	1.06	1.59	0.00
Mallassez-derived cells, donor2	11929-125I3	21.55	24.24	2.38	0.16	3.49	2.06	0.32
Mallassez-derived cells, donor3	11930-125I4	14.87	62.68	0.83	0.28	3.34	4.73	0.14
Mammary Epithelial Cell, donor1	11273-116H4	14.85	48.33	1.79	0.30	5.68	6.38	0.30
Mammary Epithelial Cell, donor2	11350-117G9	18.82	70.94	1.16	0.29	6.66	10.42	1.74
Mammary Epithelial Cell, donor3	11422-118F9	13.72	21.70	3.49	1.25	2.74	4.74	0.25
Mast cell - stimulated, donor1	11487-119E2	1.36	40.68	0.68	0.00	0.00	6.10	0.00
Mast cell, donor1	11563-120D6	0.00	25.41	0.00	0.00	0.11	6.06	0.00
Mast cell, donor2	11565-120D8	19.02	23.48	0.89	0.00	0.00	4.16	0.30
Mast cell, donor3	11566-120D9	21.61	30.84	0.68	0.45	1.13	8.55	0.23
Mast cell, donor4	11567-120E1	8.33	29.25	0.35	0.00	1.06	5.14	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	0.33	37.04	0.11	0.00	0.11	7.43	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	6.42	7.00	0.58	0.00	0.00	2.33	0.58
Mast cell, expanded, donor5	11939-126A4	0.23	22.14	0.00	0.00	0.23	6.77	0.00
Mast cell, expanded, donor8	11941-126A6	0.17	15.40	0.00	0.00	0.17	3.01	0.00
Melanocyte - dark, donor1	11502-119F8	220.79	4.97	11.84	1.69	0.20	0.00	3.58
Melanocyte - dark, donor2	11582-120F7	97.25	17.30	4.85	1.04	2.08	1.73	1.73
Melanocyte - dark, donor3	11663-122F7	159.80	8.04	8.98	2.25	0.22	1.01	2.25
Melanocyte - light, donor1	11274-116H5	126.94	4.70	5.41	2.12	0.00	0.47	2.35
Melanocyte - light, donor2	11351-117H1	137.86	16.38	6.82	0.68	0.68	2.05	3.41
Melanocyte - light, donor3	11423-118G1	67.64	7.81	6.07	2.60	0.00	0.00	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	125.16	11.25	3.02	0.83	1.04	2.39	0.73
Melanocyte, donor2 (MC+2)	12739-135I3	83.10	23.94	5.38	1.08	0.27	5.65	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	198.21	25.71	4.02	1.87	2.41	3.75	0.54
Meningeal Cells, donor1	11493-119E8	102.47	54.71	11.04	1.98	1.61	4.47	2.61
Meningeal Cells, donor2	11573-120E7	180.90	41.37	6.60	3.08	2.20	5.28	1.76
Meningeal Cells, donor3	11654-122E7	72.21	46.70	7.99	1.22	2.28	5.30	1.63
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	28.52	20.82	3.99	1.14	2.85	2.28	1.43
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	79.90	19.93	4.23	0.70	1.11	2.92	1.11
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	47.31	1.31	3.94	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	23.55	0.00	2.62	2.62	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	44.49	5.02	0.72	0.00	0.00	0.00	2.15
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	37.27	2.75	5.93	0.64	0.21	0.64	1.27
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	31.67	3.52	4.52	0.00	0.00	1.51	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	13.40	7.47	4.40	1.54	0.66	1.54	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	19.00	26.30	1.46	2.92	0.73	1.46	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	19.23	11.05	3.07	1.43	1.23	1.02	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	32.83	1.39	4.85	0.55	0.00	0.42	1.80
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	40.15	6.32	1.86	0.00	0.37	0.74	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	115.13	12.89	4.08	0.92	1.18	1.97	1.18
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	34.42	1.48	1.19	1.19	0.00	0.89	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	25.69	7.01	0.00	0.00	0.00	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	33.30	12.17	1.92	1.28	0.00	0.00	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	37.93	7.44	3.90	0.35	0.71	1.06	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	80.37	10.63	3.13	0.63	0.63	2.81	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	20.32	18.87	1.45	1.45	2.18	2.90	1.45
Mesothelial Cells, donor1	11247-116E5	88.30	82.20	6.63	1.59	3.71	3.71	1.86
Mesothelial Cells, donor2	12156-128G5	74.57	41.04	5.51	2.00	2.00	0.50	2.00
Mesothelial Cells, donor3	11402-118D7	66.27	54.56	4.34	1.30	1.66	5.06	1.52
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	0.00	1.35	0.00	0.00	0.00	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	0.00	4.19	0.00	0.00	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	0.00	1.47	0.00	0.00	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	0.31	3.10	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	0.00	2.70	0.00	0.00	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	2.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	0.00	3.75	0.00	0.00	0.00	0.75	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	0.00	2.33	0.00	0.00	0.00	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	0.00	4.67	0.00	0.00	0.00	1.02	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	0.00	2.77	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	0.00	5.31	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	0.00	2.28	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	0.00	5.09	0.00	0.00	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	0.30	2.09	0.00	0.00	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	0.25	4.01	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	0.00	2.38	0.00	0.00	0.00	0.95	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	1.11	1.11	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	0.23	1.15	0.00	0.23	0.23	0.46	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	0.00	2.52	0.00	0.00	0.21	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	0.00	1.83	0.00	0.00	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	0.43	2.57	0.00	0.00	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	0.22	2.00	0.00	0.00	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	0.66	1.75	0.00	0.00	0.22	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	0.00	1.52	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	1.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	1.63	1.63	0.00	0.00	0.00	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	0.00	2.94	0.00	0.00	0.00	0.59	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	1.92	0.96	0.00	0.00	0.00	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	0.40	2.00	0.00	0.00	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	1.37	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	1.00	3.00	0.00	0.00	0.50	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	0.44	0.88	0.00	0.00	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	2.21	2.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	0.00	0.64	0.00	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	0.50	0.99	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	2.09	0.70	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	0.00	0.34	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	0.44	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	0.36	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	0.84	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	1.25	0.83	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	0.58	0.58	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	0.00	0.60	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	0.00	1.67	0.42	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	0.00	2.77	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	1.14	0.00	0.00	0.00	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	0.00	0.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	1.29	0.86	0.00	0.00	0.00	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	0.00	0.27	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	0.60	1.20	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	0.00	0.28	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	0.00	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	0.66	0.44	0.00	0.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	0.00	0.38	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	0.28	0.00	0.28	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	0.25	2.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	0.65	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	0.00	0.29	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	0.00	1.44	0.00	0.00	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	0.00	0.41	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	0.00	0.89	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	0.00	0.00	0.00	0.00	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	0.00	7.13	1.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	0.00	2.96	0.00	0.00	0.33	0.66	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	0.00	2.10	0.00	0.00	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	0.00	5.73	0.00	0.00	0.59	1.58	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	0.00	23.28	0.00	0.00	0.00	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	0.00	4.13	0.00	0.00	0.00	1.88	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	0.00	5.33	0.00	0.00	0.00	1.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	0.00	1.02	0.00	0.00	0.00	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	0.00	6.63	0.00	0.00	0.00	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	0.00	0.73	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	0.00	1.56	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	0.00	1.07	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	7.73	3.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	0.00	0.00	0.00	0.00	0.00	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	0.00	0.42	0.00	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	2.72	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.27	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.81	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	1.51	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	34.26	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	19.57	19.57	0.00	0.00	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	14.26	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	102.33	27.36	19.60	1.72	1.72	2.37	2.37
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	79.96	4.18	12.02	1.05	0.00	0.52	2.61
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	38.05	4.00	10.68	2.67	0.00	0.67	6.01
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	43.41	2.09	4.59	6.26	0.00	0.00	4.59
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	75.87	6.85	9.32	3.61	0.00	0.76	3.23
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	145.22	3.19	19.15	1.60	3.19	0.00	7.98
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	40.80	1.36	7.48	2.04	0.00	0.00	2.72
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	66.16	1.84	22.05	1.84	0.00	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	43.53	0.84	5.86	1.67	0.42	0.00	3.77
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	53.93	4.42	13.48	2.32	0.23	0.00	3.95
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	49.72	1.89	7.84	1.89	0.27	0.27	4.05
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	73.58	1.89	7.57	2.10	0.00	0.42	4.84
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	155.89	11.13	44.54	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	42.19	1.49	6.95	0.99	0.50	0.00	3.47
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	37.08	0.00	2.44	2.17	0.00	0.00	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	46.92	0.45	7.03	2.49	0.00	0.23	3.40
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	62.54	1.14	5.06	1.47	0.00	0.00	3.76
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	57.23	0.18	5.47	0.73	0.18	0.00	2.92
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	50.39	1.06	4.77	3.71	0.00	0.00	2.65
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	30.02	0.60	4.80	1.20	0.00	0.00	2.40
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	68.26	0.33	3.61	2.30	0.00	0.00	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	48.95	0.16	3.74	1.14	0.00	0.16	1.95
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	108.12	0.18	7.06	2.47	0.00	0.00	3.17
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	49.93	0.00	2.81	2.11	0.00	0.00	2.81
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	33.10	0.46	0.00	0.92	0.00	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	44.99	0.00	3.53	1.61	0.00	0.00	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	87.60	0.34	5.86	2.07	0.00	0.69	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	144.12	2.53	10.11	2.53	0.00	0.00	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	105.82	0.22	6.02	2.67	0.00	0.00	1.78
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	42.34	0.85	5.50	2.54	0.00	0.00	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	41.06	0.24	3.32	2.14	0.00	0.24	0.95
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	45.93	0.43	4.29	1.72	0.00	0.00	3.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	90.28	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	75.97	1.33	3.67	1.67	0.00	0.00	2.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	123.09	0.00	2.25	3.16	0.00	0.00	4.06
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	52.38	1.19	3.57	2.38	0.00	0.00	2.78
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	51.08	0.00	0.93	0.93	0.00	0.00	3.71
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	41.62	0.38	1.51	1.89	0.00	0.00	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	79.52	1.63	6.52	1.63	0.00	0.00	2.61
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	78.88	0.00	1.31	1.74	0.00	0.00	3.49
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	137.95	0.00	4.98	2.71	0.00	0.00	4.52
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	64.38	0.88	5.29	5.29	0.00	0.00	4.41
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	43.21	0.00	1.99	0.00	0.00	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	61.01	0.00	5.95	2.98	0.00	0.50	2.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	65.08	0.38	4.21	3.83	0.00	0.00	2.68
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	52.63	0.30	2.72	1.51	0.00	0.91	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	106.98	1.11	7.51	2.43	0.00	0.22	3.32
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	80.64	0.68	2.03	2.03	0.00	0.00	6.10
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	137.96	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	57.92	0.61	7.93	3.05	0.00	0.00	6.10
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	69.56	0.63	3.15	3.46	0.00	0.00	4.09
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	68.10	1.21	3.03	2.72	0.00	0.30	1.82
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	49.84	1.58	1.58	2.37	0.00	0.00	4.75
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	155.31	1.13	4.53	3.40	0.00	1.13	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	55.64	0.00	5.06	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	62.36	5.59	10.44	1.49	0.37	0.25	1.86
Myoblast, donor2	11322-117D8	64.44	5.56	7.48	2.30	0.38	1.34	1.15
Myoblast, donor3	11398-118D3	73.66	15.30	9.42	2.52	0.50	2.69	2.02
NK T cell leukemia cell line:KHYG-1	10777-110G3	0.00	113.97	0.00	0.00	12.40	7.15	0.00
Natural Killer Cells, donor1	11230-116C6	0.00	91.64	0.00	0.00	9.53	11.69	0.00
Natural Killer Cells, donor2	11311-117C6	0.30	97.70	0.00	0.00	15.38	7.84	0.00
Natural Killer Cells, donor3	11387-118C1	0.18	83.19	0.00	0.00	10.12	9.75	0.00
Neural stem cells, donor1	11275-116H6	135.01	21.41	28.67	9.44	0.73	1.81	7.26
Neural stem cells, donor2	11352-117H2	186.79	1.93	21.18	15.41	0.00	0.00	7.70
Neurons, donor1	11494-119E9	47.79	0.00	4.55	4.55	0.00	0.00	2.28
Neurons, donor2	11574-120E8	87.18	1.98	11.89	3.52	0.22	0.88	3.52
Neurons, donor3	11655-122E8	44.40	0.00	2.47	2.47	0.00	0.00	7.40
Neutrophils, donor1	11233-116C9	0.00	2.78	0.00	0.00	0.00	0.93	0.00
Neutrophils, donor2	11314-117C9	0.00	17.39	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	0.00	25.04	0.00	0.00	0.61	1.22	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	60.08	7.96	4.99	0.59	0.47	1.54	1.54
Nucleus Pulposus Cell, donor2	11409-118E5	34.84	4.56	3.26	0.98	0.33	2.28	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	38.31	13.84	3.81	1.00	0.40	2.41	1.40
Olfactory epithelial cells, donor1	11933-125I7	38.54	5.78	4.27	1.24	0.28	0.41	2.20
Olfactory epithelial cells, donor2	11934-125I8	50.52	12.30	7.53	1.30	0.58	2.32	3.04
Olfactory epithelial cells, donor3	11935-125I9	44.38	15.66	6.70	1.02	1.14	2.04	2.16
Olfactory epithelial cells, donor4	11936-126A1	114.25	17.43	9.06	2.43	0.10	2.73	4.29
Oligodendrocyte - precursors, donor1	11496-119F2	82.45	116.75	6.62	1.81	4.21	6.02	1.20
Osteoblast - differentiated, donor1	11276-116H7	122.09	4.25	9.78	1.91	0.21	0.85	0.85
Osteoblast - differentiated, donor2	11353-117H3	42.30	1.14	1.14	1.14	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	41.59	3.10	3.10	0.00	0.00	0.00	0.62
Osteoblast, donor1	11277-116H8	45.54	12.12	5.08	0.78	1.37	2.74	0.39
Osteoblast, donor2	11354-117H4	70.93	44.95	7.02	2.11	3.51	7.02	2.81
Osteoblast, donor3	11426-118G4	80.33	14.75	9.60	2.13	1.60	1.78	2.31
Pancreatic stromal cells, donor1	11249-116E7	64.61	2.53	10.11	1.26	0.00	0.67	1.43
Pericytes, donor1	11491-119E6	35.05	1.11	0.67	0.89	0.22	0.00	0.78
Pericytes, donor2	11571-120E5	48.22	1.81	2.49	0.68	0.00	0.23	1.58
Pericytes, donor3	11652-122E5	57.78	6.71	4.68	0.81	0.20	1.22	1.42
Perineurial Cells, donor1	11499-119F5	87.03	47.58	7.35	0.79	1.36	4.86	2.37
Perineurial Cells, donor2	11579-120F4	140.22	20.61	5.80	1.84	1.01	1.47	1.75
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	0.00	79.68	0.00	0.00	7.97	14.34	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	0.00	58.77	0.00	0.00	7.59	3.18	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	0.00	45.17	0.00	0.00	7.12	5.44	0.00
Placental Epithelial Cells, donor1	11278-116H9	46.40	84.43	3.11	0.24	4.54	4.54	0.72
Placental Epithelial Cells, donor2	11355-117H5	78.73	76.51	3.33	1.11	5.54	5.54	0.00
Placental Epithelial Cells, donor3	11427-118G5	81.67	70.48	2.94	0.20	4.32	6.87	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	24.68	1.27	1.90	0.32	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	107.30	3.75	6.00	0.38	0.56	0.75	1.50
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	467.29	13.84	48.82	7.96	1.96	3.00	6.27
Preadipocyte - breast, donor2	11328-117E5	102.44	5.18	6.75	2.03	2.48	0.23	1.35
Preadipocyte - omental, donor1	11468-119C1	187.01	9.59	11.93	2.24	1.39	0.75	1.17
Preadipocyte - omental, donor2	11329-117E6	185.94	7.42	20.08	4.80	0.00	0.00	2.62
Preadipocyte - omental, donor3	11403-118D8	73.92	10.89	7.16	1.15	1.15	0.43	1.58
Preadipocyte - perirenal, donor1	11469-119C2	109.25	3.94	7.87	1.97	0.98	0.98	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	37.47	10.13	1.84	0.92	0.31	0.92	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	45.15	13.81	3.01	1.95	1.06	3.54	1.06
Preadipocyte - subcutaneous, donor3	11428-118G6	55.17	3.24	3.41	1.36	0.00	0.17	0.51
Preadipocyte - visceral, donor1	11280-116I2	79.55	8.76	15.84	2.24	0.56	1.21	2.70
Preadipocyte - visceral, donor2	11357-117H7	77.77	39.58	6.44	0.92	0.46	2.30	0.92
Preadipocyte - visceral, donor3	11429-118G7	58.93	7.31	8.25	2.61	0.10	1.46	1.46
Prostate Epithelial Cells (polarized), donor1	11253-116F2	5.88	114.50	0.15	0.00	15.84	3.62	0.00
Prostate Epithelial Cells, donor2	11331-117E8	30.60	64.05	2.30	1.08	4.33	2.44	0.54
Prostate Epithelial Cells, donor3	11404-118D9	3.80	102.76	0.06	0.00	7.72	2.02	0.00
Prostate Stromal Cells, donor1	11254-116F3	47.27	21.19	6.49	0.68	1.37	3.19	1.03
Prostate Stromal Cells, donor2	11332-117E9	48.59	23.31	3.23	1.26	1.08	3.41	1.08
Prostate Stromal Cells, donor3	11405-118E1	42.02	3.13	2.92	0.52	0.00	0.42	1.15
Renal Cortical Epithelial Cells, donor1	11516-119H4	13.87	70.08	1.09	0.00	2.55	4.38	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	34.52	115.61	3.60	0.49	7.07	3.67	1.80
Renal Epithelial Cells, donor1	11517-119H5	10.65	31.96	1.01	0.51	2.03	2.03	0.51
Renal Epithelial Cells, donor2	11597-120H4	17.07	49.08	2.13	0.71	4.98	2.13	2.85
Renal Epithelial Cells, donor3	11678-122H4	52.30	119.31	5.19	0.74	7.09	5.19	1.69
Renal Glomerular Endothelial Cells, donor1	11514-119H2	108.26	10.21	4.77	0.68	0.68	1.36	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	79.11	15.09	7.55	1.08	0.40	0.54	4.04
Renal Glomerular Endothelial Cells, donor3	11675-122H1	138.98	52.17	7.99	1.33	4.44	6.44	3.11
Renal Glomerular Endothelial Cells, donor4	11783-124B1	100.48	4.66	2.00	0.00	0.00	0.67	2.66
Renal Mesangial Cells, donor1	11518-119H6	29.49	29.27	4.62	0.66	3.08	2.20	0.88
Renal Mesangial Cells, donor2	11598-120H5	30.72	28.84	3.76	0.63	5.64	3.13	0.63
Renal Mesangial Cells, donor3	11679-122H5	15.26	16.92	1.11	0.00	1.66	0.83	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	13.15	89.65	1.34	0.54	7.78	5.37	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	3.80	46.81	0.00	0.00	2.53	3.37	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	23.91	35.68	2.12	0.77	2.12	2.31	1.93
Retinal Pigment Epithelial Cells, donor0	11215-116A9	31.63	34.23	1.30	0.78	1.04	4.41	1.81
Retinal Pigment Epithelial Cells, donor1	11528-119I7	40.93	33.54	1.14	0.57	3.13	2.84	1.42
Retinal Pigment Epithelial Cells, donor2	11608-120I6	8.23	11.32	0.00	0.00	0.00	3.09	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	24.59	22.58	1.51	0.25	1.76	3.26	1.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	316.58	55.46	8.55	1.07	10.16	4.14	0.80
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	61.64	6.25	13.40	1.79	0.00	0.89	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	26.42	8.81	18.71	1.65	1.65	5.50	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	48.14	6.96	23.78	3.48	0.00	2.32	4.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	76.97	9.49	16.77	1.82	0.26	1.82	3.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	49.95	7.45	17.87	1.19	0.50	1.29	3.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	61.90	9.15	17.07	1.23	0.45	2.34	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	56.32	12.03	24.81	2.23	0.87	2.60	3.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	47.55	9.21	17.71	1.63	0.35	2.45	2.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	70.96	7.63	20.11	2.31	0.00	2.31	2.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	72.15	9.17	16.70	1.23	0.55	2.88	5.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	56.42	9.08	15.73	1.36	0.30	1.06	2.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	66.12	7.71	13.26	1.97	0.36	1.79	2.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	58.67	7.32	12.05	1.58	0.29	2.30	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	50.33	8.05	14.27	0.75	0.32	0.86	3.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	53.77	5.97	16.37	1.55	0.22	1.55	4.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	80.29	9.37	16.25	1.72	0.38	2.87	4.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	62.42	10.81	21.89	1.49	0.28	2.52	3.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	70.65	8.08	23.11	1.69	0.19	2.82	3.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	88.38	8.49	20.57	2.65	0.00	2.12	5.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	64.73	10.03	18.98	2.24	0.19	1.46	3.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	56.52	6.30	19.29	1.15	0.38	1.91	3.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	74.54	8.76	18.48	1.92	0.21	2.35	3.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	61.11	5.61	15.98	1.40	0.56	0.84	3.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	61.01	7.86	17.09	1.71	0.51	2.39	3.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	80.77	8.57	16.23	1.09	0.18	1.28	4.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	50.03	8.83	17.17	2.70	0.49	1.84	3.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	58.16	8.06	14.64	2.28	0.40	1.48	2.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	73.36	9.20	15.10	1.18	0.47	3.30	4.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	51.19	8.13	19.05	2.18	0.40	1.39	3.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	58.70	7.48	18.71	2.34	0.70	1.64	4.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	55.78	9.12	15.34	2.49	0.83	1.87	3.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	67.03	10.40	22.78	1.55	0.22	2.65	4.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	64.96	4.60	17.76	2.09	0.42	0.84	2.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	64.47	9.82	18.44	1.21	0.94	2.15	4.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	71.18	7.32	23.84	2.04	0.51	1.19	5.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	62.08	6.17	20.05	1.74	0.19	1.16	3.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	67.57	8.42	22.70	1.89	1.38	2.75	4.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	69.82	7.41	19.48	2.19	0.41	1.78	4.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	73.71	5.91	25.94	1.31	0.33	1.97	5.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	84.87	10.23	20.11	0.85	1.02	2.05	4.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	57.70	7.99	21.16	2.66	0.74	1.04	2.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	73.03	8.53	20.79	2.40	0.53	0.80	4.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	71.21	10.65	18.39	2.77	0.55	1.80	5.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	62.86	5.95	19.52	0.48	0.48	0.71	2.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	92.31	8.26	34.06	2.42	0.81	1.41	5.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	59.80	8.10	22.70	1.04	0.47	1.41	4.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	64.98	12.23	21.31	1.05	1.05	0.35	4.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	57.72	8.16	17.23	3.63	0.60	0.00	4.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	57.28	6.24	19.34	1.22	0.73	1.71	3.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	98.68	14.70	35.95	3.35	0.87	4.08	4.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	54.76	9.13	15.21	0.61	0.00	1.22	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	60.58	6.63	15.37	0.90	1.21	2.11	4.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	55.87	20.13	23.30	1.58	1.58	4.07	4.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	60.81	11.98	23.96	3.00	0.90	1.50	4.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	60.93	10.98	20.78	1.89	1.65	2.60	3.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	54.43	12.17	15.58	1.49	1.92	1.71	4.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	55.29	13.82	19.23	2.40	2.40	1.20	1.80
Schwann Cells, donor1	11498-119F4	38.37	13.54	2.63	0.38	0.19	1.32	0.38
Schwann Cells, donor2	11578-120F3	13.61	40.83	0.00	0.00	0.00	6.80	3.40
Schwann Cells, donor3	11659-122F3	39.65	14.02	4.82	1.53	1.31	2.85	3.07
Sebocyte, donor1	11220-116B5	23.55	49.85	0.55	0.00	2.19	7.67	0.55
Sebocyte, donor2	11301-117B5	5.97	39.06	0.46	0.00	2.30	3.68	0.00
Sebocyte, donor3	11378-118B1	31.54	12.16	3.50	0.21	0.82	2.27	0.21
Sertoli Cells, donor1	11255-116F4	241.86	19.88	14.91	1.66	1.66	1.66	3.31
Sertoli Cells, donor2	11333-117F1	242.90	11.30	19.77	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	64.93	4.40	5.98	1.32	0.26	0.70	1.50
Skeletal Muscle Cells, donor2	11358-117H8	44.82	0.72	3.61	1.45	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	53.51	5.85	4.18	2.51	0.00	0.84	1.67
Skeletal Muscle Cells, donor4	11451-119A2	49.33	6.60	3.93	1.26	0.79	0.63	2.51
Skeletal Muscle Cells, donor5	11455-119A6	56.93	4.76	3.86	1.34	0.45	1.04	0.89
Skeletal Muscle Cells, donor6	11459-119B1	58.64	15.39	5.85	0.92	0.62	1.85	1.69
Skeletal Muscle Satellite Cells, donor1	11240-116D7	44.61	8.69	9.70	1.51	0.50	2.52	2.65
Skeletal Muscle Satellite Cells, donor2	11321-117D7	70.49	9.13	7.13	0.86	0.14	2.14	4.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	61.21	11.41	5.95	1.69	0.69	1.88	2.38
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	125.54	1.69	7.50	1.69	0.08	0.17	2.61
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	36.19	10.13	2.17	1.45	0.72	1.45	2.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	41.00	2.34	5.09	1.51	0.14	0.14	1.79
Skin - palm, donor1	10286-104F7	359.94	2.69	2.69	16.12	0.00	2.69	5.37
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	8.65	44.40	0.29	0.14	3.32	2.16	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	75.25	334.52	6.54	3.27	33.53	22.08	4.09
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	9.35	24.93	0.26	0.26	2.08	1.69	0.65
Small Airway Epithelial Cells, donor1	11256-116F5	14.60	125.39	1.39	0.00	10.15	5.70	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	13.36	115.06	1.13	0.56	5.91	4.50	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	55.61	243.80	3.38	1.48	8.88	21.57	2.11
Small Airway Epithelial Cells, donor3	11406-118E2	11.54	91.96	0.52	0.22	8.62	4.05	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	71.90	8.64	4.32	1.23	0.62	0.62	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	270.58	30.01	30.24	3.56	1.56	4.45	3.56
Smooth Muscle Cells - Aortic, donor0	11210-116A4	87.59	18.22	8.23	1.18	0.59	1.18	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	160.22	15.69	14.81	2.21	0.00	2.21	1.55
Smooth Muscle Cells - Aortic, donor2	11360-117I1	71.27	37.80	11.03	1.97	1.97	5.12	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	100.43	28.58	8.50	3.86	0.77	0.77	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	86.07	7.01	5.00	3.00	2.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	81.58	21.29	11.98	1.20	0.53	1.06	1.20
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	89.11	11.75	6.21	2.44	0.22	1.33	1.11
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	120.22	46.09	14.98	2.69	1.92	1.54	2.69
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	64.79	8.47	11.72	2.60	0.00	1.63	1.30
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	94.80	31.01	8.56	2.95	1.48	3.84	1.77
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	94.39	7.12	6.98	1.57	0.57	0.71	1.71
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	22.45	2.28	2.77	0.65	0.00	0.00	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	113.55	1.22	6.39	2.44	0.00	0.00	1.52
Smooth Muscle Cells - Carotid, donor1	11285-116I7	79.81	8.59	5.81	1.26	0.25	1.52	1.01
Smooth Muscle Cells - Carotid, donor2	11362-117I3	79.57	6.12	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	40.53	35.76	3.81	0.00	1.91	1.91	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	47.49	7.67	3.54	0.29	0.29	1.62	1.77
Smooth Muscle Cells - Colonic, donor2	11320-117D6	72.32	9.90	4.52	1.72	0.86	2.80	1.94
Smooth Muscle Cells - Colonic, donor3	11396-118D1	58.36	17.21	5.46	2.52	1.05	1.15	0.94
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	77.80	36.81	7.42	1.70	1.55	2.47	2.17
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	59.28	38.80	6.47	2.16	0.00	2.16	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	64.85	48.41	6.28	1.79	0.90	2.99	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	18.09	5.12	1.71	0.34	0.00	1.02	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	62.12	4.40	5.81	0.79	0.16	1.10	1.33
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	104.87	5.94	14.59	2.31	0.30	0.81	1.81
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	80.10	82.15	6.83	2.28	2.96	3.19	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	85.74	43.47	1.81	2.42	2.42	3.62	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	18.01	26.23	1.85	0.26	1.32	2.65	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	55.13	11.05	5.86	1.07	0.67	2.26	1.07
Smooth Muscle Cells - Prostate, donor2	11335-117F3	68.37	11.90	5.26	1.63	0.50	2.13	1.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	80.66	0.25	12.18	1.52	0.00	0.00	2.54
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	187.11	20.05	25.93	4.07	0.00	2.71	2.56
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	75.02	8.25	8.25	3.75	1.50	1.50	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	2294.97	11.63	153.77	2.58	0.00	1.29	7.75
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	103.71	18.14	10.23	2.33	0.00	1.40	2.33
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	64.12	32.82	5.55	1.01	1.51	5.05	2.02
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	72.39	28.21	4.39	0.94	1.57	1.25	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	25.07	0.59	2.95	0.59	0.00	0.29	1.18
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	77.48	12.91	10.50	1.83	0.58	3.75	2.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	91.10	0.00	7.47	1.40	0.00	0.00	3.27
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	54.55	30.80	6.91	1.30	0.72	1.87	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	34.16	20.14	4.33	1.53	0.00	1.78	1.02
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	40.80	23.32	6.21	1.13	0.94	2.82	1.32
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	46.81	21.10	5.45	0.84	1.12	3.63	1.40
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	61.92	21.03	3.69	1.01	0.50	1.51	1.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	4.76	1.43	0.48	0.00	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	57.98	29.36	7.58	1.47	0.24	1.47	2.20
Smooth Muscle Cells - Uterine, donor1	11258-116F7	59.21	3.98	4.64	1.10	0.00	1.10	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	30.14	4.10	3.22	0.88	0.00	0.29	1.46
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	96.99	0.19	4.28	0.39	0.00	0.00	0.78
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	125.62	3.70	7.67	0.53	0.26	0.26	1.06
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	44.63	0.00	12.65	1.86	0.00	0.00	2.98
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	117.50	0.00	10.78	2.87	0.00	0.00	2.52
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	83.75	2.56	9.08	2.84	0.00	0.85	2.84
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	84.68	6.30	12.60	1.18	0.00	2.76	3.54
Smooth muscle cells - airway, control, donor1	11966-126D4	79.49	0.25	5.84	0.76	0.00	0.25	2.03
Smooth muscle cells - airway, control, donor2	11967-126D5	74.27	0.00	4.39	0.80	0.00	0.00	1.60
Smooth muscle cells - airway, control, donor3	11968-126D6	74.82	0.00	2.09	0.84	0.00	0.00	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	43.09	1.83	2.75	0.92	0.00	0.00	1.38
Synoviocyte, donor1	11291-117A4	93.59	7.24	10.44	1.18	0.67	1.18	2.69
Synoviocyte, donor2	11368-117I9	94.54	1.51	6.37	0.84	0.50	0.34	1.01
Synoviocyte, donor3	11440-118H9	98.97	2.46	3.13	0.89	0.00	0.89	2.01
Trabecular Meshwork Cells, donor1	11532-120A2	28.59	13.58	3.93	0.71	0.71	2.14	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	7.93	7.93	1.98	1.98	0.00	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	30.10	8.34	2.78	0.46	0.23	0.93	0.69
Tracheal Epithelial Cells, donor1	11292-117A5	1.29	55.41	0.07	0.00	4.44	4.87	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	4.64	35.56	1.55	0.39	0.39	4.25	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	1.15	28.63	0.00	0.00	2.29	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	309.90	58.31	9.35	1.60	9.23	4.80	0.98
Urethra, donor2	10319-105A4	338.10	8.99	3.60	8.99	0.00	0.00	3.60
Urothelial Cells, donor1	11520-119H8	10.36	22.85	0.80	0.80	1.59	1.06	0.00
Urothelial Cells, donor2	11600-120H7	6.01	20.43	0.00	0.00	1.20	0.80	0.00
Urothelial Cells, donor3	11681-122H7	7.56	23.15	0.00	0.23	0.92	2.06	0.23
Urothelial cells, donor0	11216-116B1	27.42	49.48	2.01	0.67	2.23	3.12	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	0.00	70.29	0.00	0.00	4.45	9.79	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	0.00	60.04	0.00	0.00	5.72	11.44	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	0.68	39.70	0.00	0.00	4.11	3.42	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	0.00	44.76	0.00	0.00	4.82	7.58	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	0.58	48.81	0.00	0.00	6.39	3.49	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	0.00	67.68	0.00	1.04	5.21	7.29	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	0.92	69.75	0.00	0.00	7.34	4.59	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	0.00	43.82	0.00	0.00	0.91	3.65	0.00
Wilms' tumor cell line:G-401	10809-111A8	24.06	24.67	1.36	0.62	3.21	3.45	1.11
Wilms' tumor cell line:HFWT	10597-108E3	103.84	1.76	3.52	4.40	0.88	0.00	1.76
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	2.79	51.95	0.00	0.00	7.26	6.14	0.00
achilles tendon, donor2	10292-104G4	316.18	6.20	4.13	4.13	0.00	2.07	8.27
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	3.82	85.16	0.51	0.00	6.63	6.37	1.02
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	7.43	218.71	1.16	0.00	25.77	12.77	1.16
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	0.00	39.29	0.00	0.00	10.45	4.15	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	10.61	126.81	3.81	0.27	42.18	8.98	1.36
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	0.00	38.51	0.00	0.00	6.46	7.59	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	201.96	26.22	5.08	0.42	2.54	3.38	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	321.48	33.75	10.62	4.90	5.72	4.36	5.99
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	0.44	60.37	0.00	0.00	5.29	9.25	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	0.00	20.01	0.00	0.00	3.27	6.13	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	0.00	10.87	0.00	0.00	1.55	3.11	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	4.05	22.82	0.55	0.18	6.99	8.83	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	7.80	11.70	0.00	0.00	3.90	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	199.85	13.94	9.06	2.56	2.09	2.56	2.09
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	0.00	20.45	0.00	0.00	1.29	2.85	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	0.00	10.52	0.00	0.00	0.29	0.88	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	0.00	32.07	0.00	0.00	0.46	4.18	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	0.00	30.02	0.00	0.00	2.47	7.40	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	0.00	7.67	0.00	0.00	0.00	1.53	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	0.00	13.65	0.00	0.00	0.85	3.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	0.30	11.53	0.00	0.00	0.00	3.34	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	0.00	15.89	0.00	0.24	0.48	5.54	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	0.00	22.94	0.00	0.00	1.34	8.02	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	0.00	0.33	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	0.00	3.72	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	66.67	14.31	4.14	1.51	0.00	4.52	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	423.92	0.00	8.29	3.05	0.00	0.00	9.59
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	5.62	5.62	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	7.54	112.80	0.00	0.24	17.66	6.59	0.24
adipose tissue, adult, pool1	10010-101C1	779.01	6.36	21.41	2.02	0.47	0.47	2.79
adipose, donor1	10184-103D4	6.45	41.64	0.00	1.17	1.17	2.93	1.17
adipose, donor2	10185-103D5	8.92	11.35	0.41	1.22	0.41	1.22	0.81
adipose, donor3	10186-103D6	17.43	17.43	2.18	1.63	0.27	1.63	1.09
adipose, donor4	10187-103D7	122.21	39.87	2.60	0.87	1.73	2.60	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	21.15	21.46	3.31	1.10	3.95	2.84	2.05
adrenal gland, adult, pool1	10081-102A9	138.23	90.94	3.64	10.91	3.64	7.28	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	0.00	123.67	0.00	0.00	1.87	17.34	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	244.75	43.95	10.72	1.79	3.93	6.07	5.36
amniotic membrane cells, donor1	12235-129G3	119.63	130.99	0.93	0.23	7.88	9.04	0.00
amniotic membrane cells, donor2	12236-129G4	167.36	50.38	5.41	0.34	1.69	5.75	1.01
amniotic membrane cells, donor3	12237-129G5	209.46	134.04	0.29	0.00	10.31	12.08	0.29
amygdala - adult, donor10196	10167-103B5	412.66	2.37	37.95	27.27	0.00	1.19	8.30
amygdala, adult, donor10252	10151-102I7	663.66	2.23	34.27	18.65	0.20	0.00	13.99
amygdala, newborn, donor10223	10360-105E9	266.28	2.26	17.43	14.52	0.32	0.32	8.07
anaplastic carcinoma cell line:8305C	10428-106D5	176.35	14.64	5.86	0.64	1.66	0.64	2.93
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	11.03	69.28	2.43	1.10	11.47	4.63	0.88
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	52.44	11.36	5.01	5.01	3.34	2.67	3.01
aorta, adult, pool1	10052-101G7	317.74	5.49	19.42	6.28	0.59	1.37	5.30
appendix, adult	10189-103D9	232.87	41.53	12.42	4.27	3.49	1.94	2.72
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	0.00	33.02	0.00	0.00	19.60	4.47	0.00
artery, adult	10190-103E1	285.32	2.72	6.79	4.08	1.36	0.00	2.72
astrocytoma cell line:TM-31	10425-106D2	94.02	0.00	11.30	1.01	0.00	0.00	3.48
b cell line:RPMI1788	10427-106D4	8.48	135.32	3.72	0.30	11.90	4.76	1.49
basal cell carcinoma cell line:TE 354.T	10702-109G9	149.82	1.11	11.93	2.77	0.00	0.83	1.66
bile duct carcinoma cell line:HuCCT1	10432-106D9	41.48	66.09	4.56	0.69	3.87	6.65	1.69
bile duct carcinoma cell line:TFK-1	10496-107C1	0.33	82.18	0.00	0.17	8.70	6.53	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	0.00	0.56	0.00	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	271.93	13.25	10.43	3.69	1.52	1.85	1.20
blood, adult, pool1	10053-101G8	0.00	31.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	145.58	14.56	17.13	1.71	0.86	0.86	1.71
bone marrow, adult	10192-103E3	462.26	9.45	7.42	0.67	2.70	2.70	0.00
brain, adult, donor1	10084-102B3	366.97	1.03	17.43	29.73	1.03	0.00	4.10
brain, adult, pool1	10012-101C3	458.35	0.89	37.53	37.19	0.00	0.11	10.80
brain, fetal, pool1	10085-102B4	451.47	2.67	37.40	32.06	0.00	0.00	26.71
breast carcinoma cell line:MCF7	10482-107A5	36.67	27.09	0.66	0.99	3.96	6.28	1.32
breast carcinoma cell line:MDA-MB-453	10419-106C5	0.12	23.34	0.00	0.00	3.25	9.11	0.00
breast, adult, donor1	10080-102A8	664.19	5.05	12.00	5.05	0.00	0.00	3.79
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	3.94	41.03	2.16	0.25	6.10	10.67	0.51
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	22.88	41.44	4.33	0.31	6.18	11.75	1.86
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	8.98	20.72	1.61	0.23	4.14	4.83	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	21.79	0.00	2.42	0.97	0.00	0.00	0.48
carcinoid cell line:NCI-H1770	10703-109H1	27.27	16.46	8.46	1.88	6.58	0.94	7.99
carcinoid cell line:NCI-H727	10735-110B6	1.53	149.30	0.11	0.00	11.59	5.03	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	43.10	0.00	4.75	0.00	0.00	0.00	2.85
carcinosarcoma cell line:JHUCS-1	10642-109A3	86.51	0.80	14.64	2.66	0.27	0.00	13.58
caudate nucleus - adult, donor10196	10177-103C6	409.87	1.15	29.93	42.60	1.15	1.15	20.72
caudate nucleus, adult, donor10252	10164-103B2	484.58	1.34	36.81	22.09	0.17	0.17	16.40
caudate nucleus, adult, donor10258	10379-105H1	530.31	0.00	33.62	44.32	0.00	0.00	7.64
caudate nucleus, newborn, donor10223	10354-105E3	316.06	1.46	20.14	23.44	0.37	0.00	8.79
cerebellum - adult, donor10196	10173-103C2	256.37	2.91	26.22	49.53	0.00	0.00	20.39
cerebellum, adult, donor10252	10166-103B4	429.37	1.49	29.04	35.87	0.21	0.00	11.96
cerebellum, adult, pool1	10083-102B2	180.41	0.00	14.49	43.46	0.00	0.00	9.31
cerebellum, newborn, donor10223	10357-105E6	264.86	1.66	19.10	16.61	0.00	0.83	21.59
cerebral meninges, adult	10188-103D8	502.51	0.76	28.49	29.75	0.25	0.25	8.82
cerebrospinal fluid, donor2	10294-104G6	166.64	0.00	5.12	9.50	0.00	0.00	3.65
cervical cancer cell line:D98-AH2	10552-107I3	23.58	33.93	2.30	0.58	6.61	8.91	0.72
cervical cancer cell line:ME-180	10553-107I4	15.41	37.95	1.99	0.17	6.63	8.12	0.33
cervix, adult, pool1	10013-101C4	281.58	9.03	13.12	3.46	1.15	1.89	2.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	143.38	0.00	5.16	1.95	0.00	0.00	0.70
chondrosarcoma cell line:SW 1353	10700-109G7	71.84	0.00	2.61	2.61	0.00	0.00	2.61
choriocarcinoma cell line:BeWo	10423-106C9	5.72	51.82	0.00	0.00	12.43	10.81	0.00
choriocarcinoma cell line:SCH	10785-110H2	7.76	35.85	0.00	0.00	5.30	5.91	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	16.37	17.79	0.00	0.24	6.40	3.08	0.00
chorionic membrane cells, donor1	12238-129G6	45.30	23.08	1.14	0.00	3.13	3.42	0.00
chorionic membrane cells, donor2	12239-129G7	32.61	32.41	3.38	0.89	2.78	2.19	0.70
chorionic membrane cells, donor3	12240-129G8	58.25	24.18	2.20	0.55	2.20	2.20	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	0.00	39.38	0.00	0.00	17.17	6.06	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	17.87	31.50	0.19	1.15	3.07	4.23	1.34
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	0.84	10.77	0.00	0.00	0.42	2.53	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	0.00	21.83	0.00	0.00	2.05	2.31	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	0.00	25.64	0.00	0.00	3.14	1.94	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	0.00	30.34	0.00	0.00	3.66	2.44	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	0.00	29.74	0.00	0.00	0.88	5.01	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	9.38	34.66	0.26	0.52	1.56	4.43	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	9.37	45.03	0.69	0.69	7.31	1.60	0.46
clear cell carcinoma cell line:TEN	10636-108I6	0.00	77.38	0.00	0.00	7.81	2.43	0.00
colon carcinoma cell line:CACO-2	10513-107D9	9.88	94.45	0.37	0.18	19.95	4.21	0.18
colon carcinoma cell line:COLO-320	10420-106C6	45.23	0.76	3.42	2.28	0.38	0.00	1.52
colon, adult, donor1	10082-102B1	161.84	60.69	3.57	0.00	1.19	2.38	1.19
colon, adult, pool1	10014-101C5	203.40	37.01	4.94	1.41	2.70	4.94	1.41
colon, fetal, donor1	10070-101I7	126.69	53.15	3.09	4.33	1.85	2.47	6.80
common myeloid progenitor CMP, donor1	12130-128D6	82.50	73.34	0.00	4.58	18.33	9.17	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	50.07	0.00	0.00	0.00	50.07	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	19.12	0.00	4.25	1.70	0.00	0.00	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	7.24	0.00	2.11	0.75	0.00	0.00	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	8.18	0.00	3.10	0.56	0.00	0.00	0.42
corpus callosum, adult, pool1	10042-101F6	723.52	3.76	32.28	27.75	0.33	0.22	5.64
cruciate ligament, donor2	10295-104G7	492.77	3.24	14.59	4.05	0.00	2.43	4.05
diaphragm, fetal, donor1	10069-101I6	436.59	4.01	8.83	2.41	0.00	0.00	2.41
diencephalon, adult	10193-103E4	368.38	0.24	12.00	25.44	0.00	0.00	6.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	3.90	37.89	0.23	0.69	4.13	5.05	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	28.21	28.46	0.26	0.77	7.44	4.87	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	18.29	6.02	2.65	2.17	1.44	0.24	0.24
ductus deferens, adult	10196-103E7	642.36	3.99	11.46	5.48	0.50	0.00	3.49
duodenum, fetal, donor1, tech_rep1	10071-101I8	102.26	43.21	15.84	7.20	5.76	5.76	4.32
duodenum, fetal, donor1, tech_rep2	10071-101I8	203.04	46.35	8.09	3.68	8.09	8.09	1.47
dura mater, adult, donor1	10041-101F5	232.90	8.18	11.89	4.87	0.99	1.07	2.97
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	39.75	24.43	1.55	0.67	3.11	2.66	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	53.88	30.52	2.72	0.86	3.15	3.30	1.29
embryonic pancreas cell line:1B2C6	10604-108F1	24.66	24.05	1.85	0.00	3.08	3.08	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	25.43	13.32	1.21	0.61	1.21	2.12	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	33.34	27.79	1.23	0.62	3.09	2.47	1.85
embryonic pancreas cell line:2C6	10603-108E9	24.96	27.58	1.31	0.00	6.57	2.63	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	52.63	100.89	1.68	1.34	5.70	7.37	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	12.87	3.81	1.09	0.18	0.00	0.54	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	1.77	30.07	0.00	0.00	3.06	5.95	0.00
epidermoid carcinoma cell line:A431	10426-106D3	1.33	61.47	0.00	0.00	3.56	5.78	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	0.00	78.75	0.00	0.00	10.45	8.47	0.00
epididymis, adult	10197-103E8	378.64	4.60	14.02	1.47	1.26	0.42	2.51
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	58.55	31.58	9.05	2.66	1.42	3.02	4.26
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	15.73	25.17	1.18	0.39	0.79	1.57	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	1.44	45.61	0.66	0.13	17.17	10.88	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	1.67	52.36	1.08	0.10	16.83	9.84	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	1.68	42.57	1.46	0.11	12.88	9.75	0.22
esophagus, adult, pool1	10015-101C6	252.07	18.47	5.84	2.23	2.12	3.93	0.85
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	217.03	72.76	7.26	3.01	8.64	7.14	1.63
eye - muscle inferior rectus, donor1	10272-104E2	758.18	0.00	19.32	4.83	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	406.11	4.21	8.42	6.31	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	695.00	1.49	13.39	17.86	0.00	0.00	11.91
eye - muscle superior, donor2	10297-104G9	718.85	1.15	16.05	6.88	0.00	0.00	12.61
eye - vitreous humor, donor1	10268-104D7	99.10	10.20	2.91	8.74	4.37	0.00	5.83
eye, fetal, donor1	10054-101G9	233.64	42.71	12.20	6.86	4.32	1.78	5.85
fibrosarcoma cell line:HT-1080	10758-110E2	36.80	0.00	4.87	1.28	0.00	0.00	1.41
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	61.02	0.00	9.73	1.42	0.00	0.00	5.94
frontal lobe, adult, pool1	10040-101F4	603.48	0.47	51.70	40.25	0.28	0.09	11.07
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	5.10	92.78	0.30	0.00	11.71	13.21	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	61.63	52.03	2.38	0.91	6.67	3.11	0.91
gall bladder, adult	10198-103E9	345.01	59.88	10.38	3.38	7.73	6.52	1.69
gamma delta positive T cells, donor1	11937-126A2	0.00	25.23	0.00	0.00	2.15	7.52	0.00
gamma delta positive T cells, donor2	11938-126A3	0.37	32.12	0.75	0.00	2.61	5.98	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	71.81	10.14	13.52	2.75	0.84	1.06	1.48
gastric adenocarcinoma cell line:MKN45	10612-108F9	0.19	88.20	0.00	0.00	13.54	15.47	0.00
gastric cancer cell line:AZ521	10549-107H9	74.11	10.98	5.90	1.31	5.25	1.64	1.15
gastric cancer cell line:GSS	10560-108A2	56.74	5.49	3.66	0.00	5.49	0.92	2.75
gastrointestinal carcinoma cell line:ECC12	10615-108G3	8.00	72.42	0.69	0.00	6.85	3.43	0.00
giant cell carcinoma cell line:LU65	10487-107B1	1.26	38.90	0.00	0.00	8.95	2.41	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	102.17	46.61	12.74	1.54	1.26	3.36	5.74
glassy cell carcinoma cell line:HOKUG	10688-109F4	24.94	14.22	1.25	1.00	4.74	3.99	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	133.63	0.00	40.00	3.27	0.00	0.00	7.39
glioblastoma cell line:A172, tech_rep2	10444-106F3	126.68	0.00	35.11	3.79	0.00	0.00	7.02
glioblastoma cell line:T98G	10485-107A8	56.07	0.00	12.91	0.99	0.00	0.00	2.21
glioma cell line:GI-1	10413-106B8	63.85	4.10	9.08	2.34	0.29	0.29	3.22
globus pallidus - adult, donor10196	10175-103C4	389.24	1.46	20.41	45.92	0.73	0.00	8.02
globus pallidus, adult, donor10252	10161-103A8	652.95	2.93	29.78	24.90	0.24	0.00	6.10
globus pallidus, adult, donor10258	10367-105F7	722.94	1.37	20.54	23.28	0.00	0.00	4.11
globus pallidus, newborn, donor10223	10364-105F4	280.85	3.20	12.26	19.19	0.53	0.00	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	2.45	51.39	0.00	2.45	4.89	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	26.13	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	101.12	24.32	10.24	5.76	1.28	4.48	1.92
hIPS +CCl2, biol_rep1	14383-156B9	33.52	41.32	1.84	2.30	2.30	3.21	1.38
hIPS +CCl2, biol_rep2	14384-156C1	36.58	41.61	1.37	1.83	4.57	5.94	3.20
hIPS +CCl2, biol_rep3	14385-156C2	29.63	33.49	2.58	1.29	3.86	3.22	1.29
hIPS, biol_rep1	14380-156B6	23.00	23.00	1.44	0.00	8.62	7.19	1.44
hIPS, biol_rep2	14381-156B7	32.92	21.95	0.69	0.00	4.12	1.37	2.74
hIPS, biol_rep3	14382-156B8	361.94	5.52	22.07	40.83	0.00	1.10	14.35
hairy cell leukemia cell line:Mo	10712-109I1	0.29	0.00	0.00	0.00	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	875.08	5.98	29.30	6.88	0.30	0.60	4.48
heart - pulmonic valve, adult	10206-103F8	786.52	2.61	21.44	7.84	0.26	0.00	4.71
heart - tricuspid valve, adult	10207-103F9	930.89	11.66	5.83	0.83	0.83	0.00	2.50
heart, adult, diseased post-infarction, donor1	10050-101G5	158.55	35.30	6.53	1.84	6.12	5.31	1.43
heart, adult, diseased, donor1	10051-101G6	331.30	2.13	8.52	3.83	0.00	0.00	1.70
heart, adult, pool1	10016-101C7	581.15	3.91	5.29	1.84	0.23	0.23	0.69
heart, fetal, pool1	10046-101G1	602.42	12.42	28.24	3.29	0.92	0.21	5.65
hepatic mesenchymal tumor cell line:LI90	10778-110G4	171.54	18.82	10.49	2.78	0.31	1.23	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	93.94	19.03	0.00	0.00	7.14	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	145.30	135.47	4.64	2.43	39.45	5.41	1.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	141.64	133.63	6.43	3.52	42.36	6.43	2.06
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	153.90	150.67	4.65	3.23	47.29	7.17	1.62
hepatoma cell line:Li-7	10484-107A7	22.02	101.98	0.67	0.22	8.45	3.45	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	29.85	73.06	7.84	2.31	21.41	4.62	3.32
hippocampus - adult, donor10196	10169-103B7	458.02	1.89	28.39	37.85	0.95	0.00	16.09
hippocampus, adult, donor10252	10153-102I9	695.78	2.86	27.55	23.47	0.20	0.41	15.51
hippocampus, adult, donor10258	10374-105G5	416.29	1.49	30.37	39.84	0.00	0.50	10.46
hippocampus, newborn, donor10223	10363-105F3	346.49	2.11	17.27	25.03	1.06	0.70	7.40
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	25.02	84.23	2.44	0.61	4.88	8.54	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	24.94	64.80	0.79	0.59	3.34	4.12	1.37
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	34.53	54.59	1.27	0.51	4.32	5.33	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	8.46	21.43	0.00	0.00	1.69	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	10.84	29.44	0.00	0.26	2.58	1.81	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	13.29	30.37	0.76	0.00	2.28	1.90	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	14.31	16.93	2.04	2.34	0.88	1.46	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	17.88	23.27	1.72	1.08	0.43	0.86	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	26.28	14.18	1.25	0.42	2.09	2.92	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	30.07	16.34	3.55	0.71	1.66	1.89	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	29.09	20.09	2.09	0.96	1.29	2.73	0.96
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	32.32	14.81	1.35	2.02	0.67	4.71	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	31.14	53.67	1.25	1.10	1.72	3.76	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	37.83	60.43	1.97	0.49	2.95	2.46	2.46
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	27.06	47.13	1.75	0.00	3.49	7.85	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	15.08	32.45	0.19	0.19	1.53	2.48	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	10.47	30.96	0.44	0.00	0.87	0.87	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	12.49	23.99	0.00	0.50	2.00	1.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	8.48	12.25	0.94	0.75	0.19	1.51	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	10.91	14.10	2.73	0.45	2.27	1.36	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	9.71	9.40	0.63	0.00	0.94	1.57	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	21.72	12.25	2.29	0.49	0.49	2.29	1.14
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	25.26	11.61	2.32	1.74	0.87	2.03	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	23.02	7.77	2.09	1.20	0.90	0.90	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	13.67	58.75	1.29	0.55	2.77	6.28	2.40
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	19.97	71.89	2.00	0.57	2.85	4.28	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	19.19	67.78	2.04	1.22	2.45	7.35	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	16.90	32.04	1.06	0.00	1.06	2.11	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	11.09	25.97	0.32	0.32	0.63	2.85	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	8.17	22.09	0.61	0.00	2.42	3.03	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	13.96	17.07	3.10	2.07	0.00	3.10	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	12.62	10.63	1.99	0.66	1.99	1.33	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	15.91	13.85	1.28	1.03	1.54	3.59	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	29.40	18.41	4.60	1.53	0.77	3.32	1.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	18.93	21.20	1.51	1.51	1.51	3.79	3.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	25.54	13.44	3.36	1.68	0.67	2.02	1.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	11.83	62.31	0.00	0.48	3.14	5.55	1.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	17.83	44.12	0.00	0.00	1.78	4.01	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	11.71	55.12	0.00	1.46	3.41	6.34	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	11.00	33.92	0.00	0.00	0.92	2.44	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	6.51	32.53	3.25	0.00	3.25	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	12.91	34.42	0.33	0.66	1.99	2.32	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	12.04	23.53	2.19	1.09	2.19	2.74	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	10.13	19.90	1.09	1.09	1.45	1.81	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	6.05	16.73	1.42	0.00	0.71	2.49	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	13.13	29.83	1.19	0.00	0.00	1.19	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	28.85	24.78	3.11	2.17	1.35	3.93	1.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	17.51	13.74	2.16	1.08	0.00	1.08	1.08
immature langerhans cells, donor1	11904-125F5	23.97	0.97	2.18	1.21	0.00	0.48	0.48
immature langerhans cells, donor2	11905-125F6	14.26	4.75	0.00	0.00	0.00	1.58	0.00
insula, adult, pool1	10039-101F3	822.08	0.19	66.24	44.19	0.00	0.09	13.63
keratoacanthoma cell line:HKA-1	10791-110H8	3.25	5.20	0.00	0.00	1.95	3.90	0.00
kidney, adult, pool1	10017-101C8	209.97	47.56	8.51	1.50	7.41	4.41	1.50
kidney, fetal, pool1	10045-101F9	219.07	93.37	6.22	1.98	10.33	6.86	2.05
large cell lung carcinoma cell line:IA-LM	10509-107D5	35.79	19.88	11.79	1.85	3.98	2.98	7.24
large cell lung carcinoma cell line:NCI-H460	10839-111E2	64.01	23.92	4.56	1.11	18.39	2.35	2.35
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	72.85	30.46	3.12	0.92	3.30	2.75	2.02
left atrium, adult, donor1	10079-102A7	227.20	1.63	10.90	3.81	0.00	0.00	3.27
left ventricle, adult, donor1	10078-102A6	233.11	4.55	4.55	2.02	0.00	0.51	2.02
leiomyoblastoma cell line:G-402	10721-110A1	74.15	15.60	11.22	4.92	1.92	4.92	5.20
leiomyoma cell line:10964C	10569-108B2	43.11	1.08	6.47	0.72	0.00	0.00	2.16
leiomyoma cell line:15242A	10570-108B3	35.87	3.26	5.98	1.09	0.00	1.09	2.17
leiomyoma cell line:15425	10571-108B4	31.08	2.19	8.01	0.24	0.00	1.21	1.21
leiomyosarcoma cell line:Hs 5.T	10722-110A2	139.69	6.35	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	46.00	16.73	3.14	1.05	1.05	1.05	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	9.68	10.86	0.47	0.47	1.30	0.94	0.12
liposarcoma cell line:KMLS-1	10782-110G8	129.34	15.31	13.28	2.81	1.87	1.41	2.66
liposarcoma cell line:SW 872	10726-110A6	71.28	0.00	9.26	1.10	0.00	0.00	2.44
liver, adult, pool1	10018-101C9	55.10	133.21	0.81	0.16	19.77	6.64	0.32
liver, fetal, pool1	10086-102B5	15.05	36.69	0.00	0.00	5.64	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	572.22	2.33	30.19	54.83	0.29	0.00	16.33
locus coeruleus, adult, donor10252	10165-103B3	375.93	2.58	19.93	30.45	0.00	0.00	8.30
locus coeruleus, adult, donor10258	10375-105G6	258.16	0.56	17.21	36.40	0.00	0.00	8.75
locus coeruleus, newborn, donor10223	10362-105F2	192.22	5.47	17.67	11.78	0.42	0.00	3.36
lung adenocarcinoma cell line:A549	10499-107C4	41.10	76.12	2.35	1.25	12.59	4.15	1.52
lung adenocarcinoma cell line:PC-14	10408-106B3	129.61	18.61	11.72	1.38	2.76	2.76	2.07
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	0.00	39.81	0.00	0.00	4.22	3.69	0.00
lung, adult, pool1	10019-101D1	648.40	40.75	20.08	2.01	2.84	3.07	2.24
lung, fetal, donor1	10068-101I5	1547.48	105.32	46.52	7.99	8.28	4.28	7.14
lung, right lower lobe, adult, donor1	10075-102A3	559.48	13.29	22.91	3.67	0.92	0.92	4.12
lymph node, adult, donor1	10077-102A5	82.37	14.67	3.79	0.00	1.42	1.89	0.47
lymphangiectasia cell line:DS-1	10727-110A7	0.00	46.25	0.00	0.00	7.67	3.29	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	43.77	16.60	11.17	1.21	7.85	0.75	4.53
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	5.10	83.25	0.00	0.00	8.49	12.74	0.00
mature adipocyte, donor1	12231-129F8	2545.84	1.33	19.98	11.10	0.00	0.00	5.33
mature adipocyte, donor2	12232-129F9	2781.50	2.28	29.47	11.41	0.21	0.00	3.94
mature adipocyte, donor3	12233-129G1	1956.48	0.95	34.14	10.19	0.24	0.00	2.37
mature adipocyte, donor4	12234-129G2	1369.78	0.53	18.69	7.37	0.00	0.26	1.84
maxillary sinus tumor cell line:HSQ-89	10414-106B9	23.35	31.21	2.14	0.24	6.91	4.77	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	331.64	0.00	37.23	43.99	0.00	0.00	6.77
medial frontal gyrus, adult, donor10252	10150-102I6	554.48	4.23	31.45	31.26	0.92	0.37	16.37
medial frontal gyrus, adult, donor10258	10368-105F8	372.97	0.00	23.83	44.79	0.00	0.00	12.07
medial frontal gyrus, newborn, donor10223	10352-105E1	291.72	5.97	35.40	8.10	0.43	0.43	4.26
medial temporal gyrus - adult, donor10196	10183-103D3	488.70	2.70	38.98	41.34	0.34	0.00	12.83
medial temporal gyrus, adult, donor10252	10156-103A3	581.07	2.55	35.44	31.62	0.21	0.00	13.37
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	217.67	0.00	23.12	21.19	0.00	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	602.85	0.00	43.06	71.77	0.00	0.00	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	386.57	3.95	27.28	15.43	1.08	0.72	7.90
medulla oblongata - adult, donor10196	10174-103C3	345.91	1.30	19.47	25.31	0.00	0.65	9.73
medulla oblongata, adult, donor10252	10155-103A2	416.58	2.79	18.11	22.45	0.77	0.31	6.81
medulla oblongata, adult, pool1	10038-101F2	615.80	3.02	38.20	32.00	0.33	0.65	8.65
medulla oblongata, newborn, donor10223	10361-105F1	353.08	2.08	15.28	16.66	0.35	0.00	5.90
medulloblastoma cell line:D283 Med	10838-111E1	138.16	0.00	8.86	3.32	0.00	0.00	5.98
medulloblastoma cell line:ONS-76	10759-110E3	20.91	34.73	3.79	0.86	6.11	4.52	1.22
melanoma cell line:COLO 679	10514-107E1	277.57	40.97	18.69	3.59	3.16	1.87	2.01
melanoma cell line:G-361	10465-106H6	47.78	0.00	5.97	3.53	0.00	0.00	1.90
meningioma cell line:HKBMM	10691-109F7	19.72	57.89	1.27	0.00	1.99	6.33	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	0.00	92.52	0.00	0.00	11.46	22.91	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	15.29	52.62	9.59	1.81	9.07	10.89	1.81
mesenchymal precursor cell - adipose, donor1	11747-123G1	69.66	5.83	7.98	0.92	0.15	0.77	1.38
mesenchymal precursor cell - adipose, donor2	11748-123G2	32.36	0.55	1.27	0.91	0.00	0.00	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	65.43	1.24	6.63	1.24	0.00	1.24	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	46.36	1.12	5.90	0.84	0.00	0.00	1.55
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	40.05	0.39	4.43	1.35	0.19	0.19	1.16
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	66.63	0.69	3.47	1.39	0.00	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	88.91	3.26	10.30	0.86	0.00	0.34	1.03
mesenchymal precursor cell - cardiac, donor2	11753-123G7	98.57	2.76	6.56	1.73	0.35	0.00	1.38
mesenchymal precursor cell - cardiac, donor3	11754-123G8	102.93	14.99	9.55	1.59	0.40	1.06	0.80
mesenchymal precursor cell - cardiac, donor4	11755-123G9	60.90	44.56	8.10	0.81	1.08	2.16	0.95
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	87.63	44.39	9.39	2.13	1.42	5.41	2.70
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	54.67	7.58	3.29	0.33	0.99	1.98	1.98
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	83.99	41.23	4.15	2.77	0.69	2.63	1.52
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	117.99	31.42	11.52	2.44	1.40	2.09	2.44
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	85.95	14.70	6.94	2.45	0.00	2.25	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	74.77	16.53	5.39	1.80	1.08	2.52	3.59
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	84.93	12.62	4.34	1.34	0.21	1.66	1.76
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	103.28	31.01	9.12	1.60	1.60	1.60	1.82
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	85.17	36.92	11.33	2.52	0.84	10.07	2.94
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	71.88	14.05	5.08	1.20	0.30	1.79	1.20
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	79.04	41.93	5.16	0.96	1.66	2.45	1.31
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	63.32	4.42	3.68	2.58	0.37	0.74	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	117.61	27.47	12.02	2.86	2.00	3.15	3.43
mesenchymal stem cell line:Hu5/E18	10568-108B1	92.62	29.89	8.84	1.26	1.26	4.21	7.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	79.46	3.20	9.59	0.46	0.00	0.91	3.20
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	81.85	1.28	7.16	2.30	0.00	0.26	1.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	86.90	1.83	6.02	2.09	0.00	1.05	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	94.27	1.85	7.70	1.23	0.31	0.00	1.54
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	84.49	1.41	9.65	1.18	0.47	0.24	2.82
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	80.55	1.35	9.14	1.69	0.00	0.34	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	77.42	0.39	7.47	3.14	0.00	0.00	1.96
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	79.70	1.85	7.88	2.78	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	109.02	1.44	8.65	1.15	0.00	0.29	1.73
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	98.39	2.01	8.70	2.23	0.22	0.45	2.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	92.30	2.64	6.97	1.20	0.00	0.24	1.92
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	211.20	2.93	8.80	2.20	0.00	2.20	3.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	87.61	1.68	6.71	0.67	1.01	0.00	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	77.37	1.23	9.42	2.05	0.82	0.00	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	92.78	2.15	10.74	1.72	0.00	0.00	3.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	117.58	0.00	8.20	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	92.97	0.00	10.33	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	102.96	1.62	8.77	2.60	0.32	0.65	2.27
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	96.03	0.00	5.82	2.91	0.00	0.00	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	99.69	1.60	8.00	2.13	0.00	0.53	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	105.49	2.45	4.91	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	95.24	1.17	7.77	1.94	0.00	0.39	1.94
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	58.76	0.00	2.10	8.39	0.00	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	96.37	2.98	3.97	1.99	0.00	0.99	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	85.81	0.00	9.53	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	110.29	1.19	7.71	4.15	0.00	0.59	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	126.72	0.00	12.18	3.66	0.00	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	108.21	0.00	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	131.74	1.27	11.40	3.17	0.63	0.63	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	114.16	0.00	5.86	0.69	0.34	0.00	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	73.07	0.00	8.60	2.15	0.00	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	79.84	0.00	7.98	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	44.77	0.00	6.89	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	41.97	0.00	2.44	1.63	0.00	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	47.67	0.00	3.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	62.49	0.00	1.18	0.59	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	58.91	0.31	1.87	0.31	0.00	0.00	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	62.82	0.00	1.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	104.08	0.00	0.00	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	110.42	2.57	5.14	5.14	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	111.52	0.69	2.75	2.07	0.00	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	274.12	0.00	4.45	2.97	0.00	0.00	2.47
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	220.94	0.00	4.49	1.12	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	230.89	0.00	3.18	3.18	0.00	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	201.89	0.00	5.24	1.61	0.00	0.00	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	207.16	0.00	4.36	2.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	187.52	0.00	2.53	7.60	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	200.88	0.00	3.03	3.64	0.00	0.00	2.43
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	212.39	0.00	4.52	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	177.09	0.00	2.47	4.12	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	112.11	0.20	3.37	1.79	0.00	0.00	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	90.53	0.00	3.24	1.62	0.00	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	127.33	0.00	3.06	1.02	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	543.92	3.09	20.89	5.42	0.00	0.00	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	191.36	71.58	22.92	2.36	5.20	2.60	4.25
mesothelioma cell line:ACC-MESO-4	10494-107B8	154.29	17.61	10.19	2.78	3.71	2.78	1.85
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	85.47	17.09	12.82	4.27	0.00	4.27	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	41.61	26.20	3.90	0.51	1.54	2.06	0.72
mesothelioma cell line:Mero-25	10850-111F4	33.59	57.87	2.72	0.91	3.18	2.72	0.45
mesothelioma cell line:Mero-41	10851-111F5	59.65	33.74	12.47	1.71	2.20	5.62	2.93
mesothelioma cell line:Mero-48a	10852-111F6	40.52	29.45	7.53	0.89	3.10	4.21	1.77
mesothelioma cell line:Mero-82	10853-111F7	36.00	42.57	6.57	1.58	6.31	3.94	1.58
mesothelioma cell line:Mero-83	10854-111F8	59.58	43.58	11.06	0.17	3.74	4.77	1.70
mesothelioma cell line:Mero-84	10855-111F9	110.97	31.60	16.18	0.51	5.06	3.79	1.01
mesothelioma cell line:Mero-95	10856-111G1	45.96	26.92	6.63	1.45	2.48	3.93	2.28
mesothelioma cell line:NCI-H2052	10847-111F1	132.19	26.17	19.71	2.15	3.81	3.64	4.14
mesothelioma cell line:NCI-H226	10846-111E9	27.15	16.47	1.99	0.90	2.17	2.17	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	50.22	33.31	16.57	1.20	2.05	5.12	1.88
mesothelioma cell line:NCI-H28	10845-111E8	34.86	94.41	6.62	1.53	24.68	5.34	2.29
mesothelioma cell line:No36	10857-111G2	34.90	15.66	5.22	0.98	1.96	2.28	0.33
mesothelioma cell line:ONE58	10858-111G3	55.82	13.01	7.04	0.81	1.08	1.08	1.35
migratory langerhans cells, donor1	11901-125F2	47.02	0.77	5.37	0.58	0.00	0.19	2.69
migratory langerhans cells, donor2	11902-125F3	62.16	0.49	3.30	0.61	0.00	0.00	1.22
migratory langerhans cells, donor3	11903-125F4	27.28	0.36	3.59	0.54	0.00	0.00	1.44
mixed mullerian tumor cell line:HTMMT	10689-109F5	25.47	5.55	0.65	0.98	0.33	0.00	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	43.02	26.28	4.24	0.64	4.66	1.91	1.27
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	1.15	114.95	0.00	0.00	5.99	5.07	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	0.00	2.28	0.00	0.00	0.00	0.19	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	1.29	55.81	0.18	0.18	3.51	7.76	0.00
myeloma cell line:PCM6	10474-106I6	0.00	32.81	0.00	0.00	2.77	4.15	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	103.49	27.39	2.54	0.51	2.03	4.06	3.04
myxofibrosarcoma cell line:NMFH-1	10684-109E9	61.39	20.99	2.75	1.18	1.37	2.55	1.37
nasal epithelial cells, donor1, tech_rep1	12226-129F3	0.45	80.45	0.00	0.00	7.91	3.90	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	0.22	71.92	0.07	0.00	6.55	3.68	0.00
nasal epithelial cells, donor2	12227-129F4	28.70	92.18	0.55	0.55	6.07	3.86	0.00
neuroblastoma cell line:CHP-134	10508-107D4	96.63	1.61	28.30	6.67	1.15	0.46	24.62
neuroblastoma cell line:NB-1	10539-107G8	231.61	17.77	48.27	11.23	0.56	3.18	9.54
neuroblastoma cell line:NBsusSR	10607-108F4	25.10	19.61	1.48	0.00	1.69	2.32	1.48
neuroblastoma cell line:NH-12	10555-107I6	74.17	43.61	23.67	4.66	2.42	8.57	19.75
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	101.77	0.00	5.69	2.14	0.24	0.00	2.14
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	30.41	10.14	1.27	0.00	0.32	2.69	1.11
neuroectodermal tumor cell line:TASK1	10774-110F9	0.40	11.67	0.00	0.00	6.84	3.42	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	7.63	8.26	0.00	0.64	0.00	0.64	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	115.78	15.97	9.05	1.06	1.06	2.13	4.26
neutrophil PMN, donor1	12133-128D9	14.87	14.87	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	13.28	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	47.35	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	48.03	133.44	5.92	0.51	37.38	6.76	3.89
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	120.88	35.22	37.62	19.21	5.60	1.60	8.01
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	37.83	2.56	5.13	0.64	0.00	1.60	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	39.15	6.31	5.26	1.31	0.00	1.31	0.26
nucleus accumbens, adult, pool1	10037-101F1	722.17	0.84	52.49	40.40	0.09	0.09	12.09
occipital cortex - adult, donor10196	10172-103C1	428.56	2.06	35.03	49.45	0.00	0.00	12.36
occipital cortex, adult, donor10252	10163-103B1	721.63	4.29	32.20	37.30	0.00	0.00	12.61
occipital cortex, newborn, donor10223	10355-105E4	453.47	5.10	33.12	20.38	0.00	0.00	12.74
occipital lobe, adult, donor1	10076-102A4	536.34	0.52	42.51	48.54	0.00	0.00	16.27
occipital lobe, fetal, donor1	10073-102A1	393.06	0.86	51.49	39.48	0.00	0.00	35.19
occipital pole, adult, pool1	10036-101E9	535.73	0.16	34.06	38.32	0.00	0.08	10.49
olfactory region, adult	10195-103E6	483.74	0.19	33.63	35.34	0.00	0.00	10.51
optic nerve, donor1	10277-104E7	660.35	0.00	20.01	40.02	2.00	0.00	12.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	36.34	66.41	5.81	1.71	15.72	6.38	0.80
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	7.01	53.86	0.41	0.41	5.63	6.59	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	0.00	23.20	0.00	0.00	1.35	6.10	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	2.89	33.96	0.81	0.23	4.74	6.58	0.69
osteoclastoma cell line:Hs 706.T	10704-109H2	212.54	0.00	16.76	4.70	0.00	0.00	2.35
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	83.16	25.23	1.87	1.87	0.93	4.67	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	50.89	5.73	5.30	0.85	2.12	2.12	2.33
ovary, adult, pool1	10020-101D2	287.91	6.20	9.17	3.76	0.35	0.87	2.80
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	34.10	19.25	4.58	0.55	1.28	1.47	0.92
pancreas, adult, donor1	10049-101G4	48.91	47.03	1.88	0.00	5.64	15.99	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	0.00	21.80	0.00	0.00	3.63	8.95	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	47.87	32.88	6.81	0.51	2.56	1.87	0.68
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	50.17	225.52	2.65	0.50	10.27	7.45	0.00
paracentral gyrus, adult, pool1	10035-101E8	553.16	0.46	43.29	50.34	0.18	0.00	11.07
parietal cortex, adult, donor10258	10373-105G4	352.32	0.73	25.69	28.63	0.00	0.00	10.28
parietal lobe - adult, donor10196	10171-103B9	354.56	0.00	23.51	42.32	0.94	0.00	15.05
parietal lobe, adult, donor10252	10157-103A4	515.35	2.28	28.79	28.22	0.86	0.29	13.68
parietal lobe, adult, pool1	10034-101E7	616.48	0.62	46.53	48.29	0.00	0.09	11.63
parietal lobe, fetal, donor1	10072-101I9	462.61	3.88	30.06	22.31	0.00	0.97	32.00
parietal lobe, newborn, donor10223	10356-105E5	421.71	6.36	29.53	19.07	0.37	0.00	10.09
parotid gland, adult	10199-103F1	127.65	25.28	3.70	1.23	8.63	12.95	1.85
penis, adult	10200-103F2	416.26	8.06	16.65	3.76	0.00	1.07	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	21.57	6.51	1.86	0.00	0.19	1.49	2.23
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	8.45	54.49	1.31	0.00	9.62	8.01	0.15
pineal gland - adult, donor10196	10179-103C8	347.02	0.65	36.77	19.35	0.65	0.00	14.84
pineal gland, adult, donor10252	10160-103A7	297.88	1.18	30.80	15.40	0.59	0.00	7.11
pineal gland, adult, donor10258	10377-105G8	327.96	0.63	30.73	14.42	0.00	0.00	7.52
pituitary gland - adult, donor10196	10180-103C9	143.68	7.08	30.35	15.18	1.01	0.00	8.09
pituitary gland, adult, donor10252	10162-103A9	311.14	9.90	45.86	16.68	5.21	1.56	14.59
pituitary gland, adult, donor10258	10378-105G9	108.11	5.11	36.60	9.36	0.00	0.85	9.36
placenta, adult, pool1	10021-101D3	193.72	16.45	6.99	0.97	1.61	2.80	1.40
plasma cell leukemia cell line:ARH-77	10840-111E3	5.16	60.39	1.46	0.26	10.73	2.25	0.79
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	132.29	9.03	18.37	1.09	0.62	0.78	1.09
pons, adult, pool1	10033-101E6	429.13	2.15	48.46	59.47	0.17	0.00	18.59
postcentral gyrus, adult, pool1	10032-101E5	549.29	0.35	43.33	48.21	0.09	0.00	11.25
promyelocytes/myelocytes PMC, donor1	12132-128D8	2.09	23.01	0.00	4.18	8.37	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	16.52	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	23.47	0.00	0.00	0.00	11.74	0.00
prostate cancer cell line:DU145	10490-107B4	25.78	35.54	6.55	0.58	6.99	4.52	1.17
prostate cancer cell line:PC-3	10439-106E7	18.15	57.35	2.90	0.36	8.53	9.80	0.36
prostate, adult, pool1	10022-101D4	310.07	9.98	13.51	2.18	0.63	1.72	2.27
putamen, adult, donor10196	10176-103C5	495.26	0.24	45.80	39.66	0.71	0.00	13.93
putamen, adult, donor10252	10152-102I8	523.51	1.96	13.73	25.49	0.00	0.00	9.80
putamen, adult, donor10258, tech_rep1	10372-105G3	166.11	18.58	4.37	22.95	1.09	2.19	8.74
putamen, adult, donor10258, tech_rep2	10372-105G3	532.27	0.48	25.85	32.86	0.24	0.00	9.91
putamen, newborn, donor10223	10365-105F5	162.68	2.25	26.99	14.24	0.00	0.00	6.75
rectal cancer cell line:TT1TKB	10469-106I1	8.15	70.99	0.00	0.00	4.95	5.82	0.00
rectum, fetal, donor1	10067-101I4	268.46	18.08	38.95	23.65	0.00	0.00	20.86
renal cell carcinoma cell line:OS-RC-2	10411-106B6	43.88	26.29	5.30	1.27	2.76	2.54	1.70
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	50.12	64.20	4.56	0.00	2.49	1.66	2.49
retina, adult, pool1	10030-101E3	492.82	29.32	21.47	8.15	3.88	4.17	3.58
retinoblastoma cell line:Y79	10475-106I7	22.34	30.40	0.78	0.26	6.24	5.98	1.30
rhabdomyosarcoma cell line:KYM-1	10787-110H4	372.29	0.00	9.22	4.67	0.00	0.00	2.70
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	307.91	5.91	6.75	1.41	0.56	0.84	3.37
sacrococcigeal teratoma cell line:HTST	10695-109G2	136.41	3.03	2.27	3.03	0.00	0.76	3.03
salivary acinar cells, donor1	11771-123I7	36.74	16.35	1.78	0.65	3.72	5.02	0.49
salivary acinar cells, donor2	11772-123I8	38.55	30.84	2.48	0.41	3.99	7.16	0.96
salivary acinar cells, donor3	11773-123I9	58.26	14.57	0.66	3.31	1.99	2.65	0.00
salivary gland, adult, pool1	10093-102C3	176.16	57.20	2.86	1.72	6.86	22.88	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	43.84	15.85	5.56	1.43	0.67	1.77	3.12
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	32.80	15.40	4.23	1.18	0.71	1.53	3.64
seminal vesicle, adult	10201-103F3	639.65	2.12	10.58	6.88	1.06	0.00	3.17
serous adenocarcinoma cell line:JHOS-2	10639-108I9	21.86	25.99	2.92	0.73	3.89	3.40	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	58.63	20.89	3.27	1.76	1.26	1.26	2.01
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	59.21	42.15	3.01	1.00	5.02	7.02	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	3.09	19.07	0.00	0.00	2.28	1.21	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	0.00	154.08	0.00	0.00	19.23	6.08	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	0.77	75.09	0.00	0.00	10.06	7.74	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	200.03	0.00	8.51	3.55	0.71	0.00	3.55
skeletal muscle, adult, pool1	10023-101D5	152.56	3.12	4.92	2.04	0.00	0.36	0.96
skeletal muscle, fetal, donor1	10066-101I3	209.04	6.03	10.05	3.02	0.00	0.00	12.06
skin, adult, donor1	10074-102A2	176.42	6.79	20.36	6.79	0.00	0.00	6.79
skin, fetal, donor1	10065-101I2	318.14	15.15	13.89	3.79	1.26	3.16	3.79
small cell cervical cancer cell line:HCSC-1	10800-110I8	28.35	30.68	22.68	2.33	4.34	1.00	7.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	85.42	26.79	30.89	1.89	10.40	3.78	7.56
small cell lung carcinoma cell line:DMS 144	10841-111E4	69.77	0.19	0.77	4.43	0.00	0.00	2.89
small cell lung carcinoma cell line:LK-2	10541-107H1	47.64	69.56	13.35	0.99	4.78	8.41	2.64
small cell lung carcinoma cell line:NCI-H82	10842-111E5	25.58	25.74	1.93	1.29	0.64	0.48	4.34
small cell lung carcinoma cell line:WA-hT	10562-108A4	103.07	108.30	22.23	3.05	7.85	5.45	4.79
small intestine, adult, pool1	10024-101D6	99.73	132.34	2.75	1.55	6.93	10.51	0.96
small intestine, fetal, donor1	10064-101I1	60.44	35.38	4.91	2.70	3.93	3.93	2.21
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	46.16	32.83	12.82	1.03	4.62	5.13	1.54
smooth muscle, adult, pool1	10048-101G3	273.70	2.58	9.82	4.14	0.52	0.52	4.39
somatostatinoma cell line:QGP-1	10781-110G7	84.69	14.74	16.35	3.75	3.75	1.88	4.56
spinal cord - adult, donor10196	10181-103D1	421.42	1.61	24.78	36.02	0.23	0.00	8.95
spinal cord, adult, donor10252	10159-103A6	384.41	2.76	23.66	18.92	0.00	0.00	4.73
spinal cord, adult, donor10258	10369-105F9	282.94	1.38	18.68	14.53	0.00	0.00	4.84
spinal cord, fetal, donor1	10056-101H2	406.15	4.88	21.34	33.54	0.61	0.61	9.15
spinal cord, newborn, donor10223	10359-105E8	304.00	2.76	16.07	12.86	0.46	0.46	4.59
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	105.74	14.94	8.07	2.39	0.90	2.99	3.14
spleen, adult, pool1	10025-101D7	313.22	24.23	6.94	1.87	2.64	3.30	0.55
spleen, fetal, pool1	10044-101F8	353.02	59.19	13.11	2.22	4.45	2.15	1.75
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	0.00	115.93	0.00	0.00	11.70	7.97	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	5.51	84.30	1.14	0.19	6.27	4.37	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	75.83	72.34	5.24	0.35	17.47	15.73	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	5.47	63.72	0.00	0.78	4.30	2.35	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	4.50	35.79	0.56	0.00	5.97	6.08	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	26.26	7.62	8.05	0.85	1.69	0.85	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	82.92	56.27	8.04	1.27	4.23	5.50	0.85
stomach, fetal, donor1	10062-101H8	250.97	44.85	13.88	8.54	0.00	1.07	5.34
submaxillary gland, adult	10202-103F4	186.86	38.74	6.27	2.28	9.68	13.10	0.57
substantia nigra - adult, donor10196	10178-103C7	271.37	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	361.82	2.08	21.60	20.15	0.00	0.00	3.74
substantia nigra, adult, donor10258	10371-105G2	363.63	0.00	16.03	38.79	0.00	0.00	7.76
substantia nigra, newborn, donor10223	10358-105E7	331.38	2.12	12.72	13.42	0.71	0.00	5.65
synovial sarcoma cell line:HS-SY-II	10441-106E9	58.23	7.57	8.25	1.38	3.67	4.36	2.52
temporal lobe, adult, pool1	10031-101E4	581.19	0.59	43.74	41.28	0.17	0.08	11.70
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	397.45	0.71	34.19	22.79	0.00	0.00	13.53
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	350.75	3.08	16.26	13.19	0.44	1.32	8.79
tenocyte, donor1	11763-123H8	69.82	3.14	5.59	2.09	0.00	0.35	1.05
tenocyte, donor2	11765-123I1	60.66	1.14	2.67	0.00	0.00	0.00	1.91
tenocyte, donor3	11768-123I4	78.95	1.48	5.19	0.74	0.00	1.85	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	29.40	123.05	2.04	0.68	1.70	10.03	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	0.00	1.08	0.15	0.00	0.00	0.00	0.15
teratocarcinoma cell line:PA-1	10807-111A6	19.53	59.36	2.48	0.15	1.86	3.72	1.39
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	66.90	56.36	4.06	0.51	1.90	4.82	1.27
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	32.90	82.82	7.19	2.27	9.45	12.10	3.40
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	117.02	31.74	6.87	1.09	2.84	4.80	2.73
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	7.82	62.21	0.33	0.00	11.07	3.91	0.00
testis, adult, pool1	10026-101D8	302.04	4.83	12.46	4.29	7.30	1.40	2.79
testis, adult, pool2	10096-102C6	289.60	5.86	9.02	4.51	19.40	1.35	3.16
thalamus - adult, donor10196	10168-103B6	383.08	3.31	18.77	43.06	1.10	0.00	12.14
thalamus, adult, donor10252	10154-103A1	540.43	2.19	26.72	18.91	0.31	0.16	7.03
thalamus, adult, donor10258, tech_rep1	10370-105G1	173.98	0.00	21.55	43.11	0.00	0.00	7.70
thalamus, adult, donor10258, tech_rep2	10370-105G1	296.44	0.66	12.35	35.90	0.16	0.16	6.09
thalamus, newborn, donor10223	10366-105F6	209.99	1.15	19.56	21.29	0.00	0.58	19.56
throat, adult	10209-103G2	331.06	15.48	8.99	2.75	4.74	3.25	1.75
throat, fetal, donor1	10061-101H7	287.34	14.93	12.19	4.27	0.91	1.83	2.74
thymic carcinoma cell line:Ty-82	10803-111A2	34.78	5.96	1.99	0.60	3.18	3.58	0.20
thymus, adult, pool1	10027-101D9	20.48	47.22	0.99	0.20	13.62	6.66	0.30
thymus, fetal, pool1	10043-101F7	71.38	49.25	3.32	0.42	11.74	6.13	0.94
thyroid carcinoma cell line:KHM-5M	10776-110G2	34.97	36.56	3.46	0.80	2.53	3.46	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	47.36	38.55	6.71	0.56	3.07	3.91	1.82
thyroid, adult, pool1	10028-101E1	331.63	8.21	5.04	0.47	1.12	1.12	0.65
thyroid, fetal, donor1	10060-101H6	402.09	7.12	12.92	2.11	1.05	0.26	3.16
tongue epidermis (fungiform papillae), donor1	10288-104F9	492.74	9.24	12.32	3.08	3.08	3.08	3.08
tongue, adult	10203-103F5	243.97	8.14	10.00	0.70	2.09	3.72	0.70
tongue, fetal, donor1	10059-101H5	179.31	14.98	13.01	2.76	0.79	2.76	4.34
tonsil, adult, pool1	10047-101G2	99.88	57.30	7.01	1.00	5.71	8.11	1.10
trachea, adult, pool1	10029-101E2	158.44	37.38	4.17	0.74	5.07	4.66	0.74
trachea, fetal, donor1	10058-101H4	229.66	21.93	10.00	3.08	2.69	2.31	3.85
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	60.58	4.96	8.15	1.77	0.00	2.13	2.48
transitional-cell carcinoma cell line:5637	10418-106C4	48.43	73.45	4.86	0.51	8.00	6.69	1.52
transitional-cell carcinoma cell line:JMSU1	10492-107B6	36.82	67.22	4.07	0.94	2.51	10.34	0.94
tridermal teratoma cell line:HGRT	10694-109G1	140.79	7.61	7.61	3.81	1.90	0.00	7.61
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	50.87	153.39	6.52	1.44	12.11	6.86	2.03
umbilical cord, fetal, donor1	10057-101H3	150.23	25.04	10.43	0.00	2.09	2.09	6.26
uterus, adult, pool1	10100-102D1	548.74	9.04	19.79	4.78	0.68	1.19	5.29
uterus, fetal, donor1	10055-101H1	190.44	11.77	9.21	3.07	1.02	1.02	2.56
vagina, adult	10204-103F6	743.13	8.40	10.34	1.94	1.29	0.65	0.65
vein, adult	10191-103E2	311.92	23.45	10.30	1.10	3.29	3.29	1.75
xeroderma pigentosum b cell line:XPL 17	10563-108A5	1.60	57.15	0.27	0.27	6.94	2.67	0.00